Podcasts about Rx

Hey Voices from the Bench community! Jessica Love here, sending a shoutout from Utah! If you're passionate about creating natural, beautiful smiles—but want to simplify your workflow without sacrificing aesthetics—this is for you. I'm honored to be part of Ivoclar's development team introducing a powerful new stain and glaze system featuring Structure Paste, IPS e.max Ceram Art. Create stunning depth and lifelike color in as little as one firing. Let's continue to innovate, simplify, and create meaningful change—one smile at a time. Elvis actually made it down to the exhibition halls this year — and hyperDENT from FOLLOW-ME! Technology was everywhere. Booth after booth, people were talking milling strategies, templates, and workflows. It felt like a full-on CAM takeover. Their Milling Roadmap scavenger hunt had attendees bouncing between Axsys, Imagine, D.O.F., and Roland collecting stamps like responsible adults… Responsible adults chasing a bright orange folding electric hyperDENT scooter. That's what we love about the FOLLOW-ME! team — world-class CAM engineers talking microns and validation protocols one minute, then ripping around Lab Day the next. Serious about precision. Not too serious about themselves. Big shoutout for bringing the brains — and the electric horsepower. Come see and talk to Elvis and Barb at all these amazing shows in 2026* Dental Lab Association of Texas Meeting in Dallas Apr 9-11 https://members.dlat.org/ exocad Insights in Mallorca, Spain Apr 30 - May 1 https://exocad.com/insights-2026 Live from the Ivoclar stage at LMT Lab Day Chicago 2026, Elvis and Barb sits down with two very different innovators shaping the future of the dental lab world. First up is industry veteran Rob Fletcher, who shares the story behind ACES (Automated Case Entry Software)—a system designed to eliminate one of the biggest bottlenecks in dental labs: manually entering handwritten prescriptions. Drawing on years of lean manufacturing experience running labs like Knight Dental Group and Bayshore Dental Studio, Rob explains how combining OCR and AI can read RX forms, learn lab terminology, and automate case entry directly into an LMS. The result? Faster workflows, fewer data entry headaches, and one less department that labs have to constantly hire and retrain. Then the conversation shifts to collaboration and innovation as Don Bell and Andreas Klie discuss a new partnership between Ivoclar and Panthera Dental. They break down how Panthera's Fusion Bar technology works with Ivoclar materials to simplify full-arch workflows while improving precision, aesthetics, and efficiency. The team also dives into the education behind the technology, the launch of the Panthera Academy, and how collaboration between companies—and listening to technicians—helps push the industry forward. Hey, listeners—ever wonder what Elvis is doing when he's not recording Voices from the Bench? He's a client rep for Derby Dental Laboratory, out in the field every day doing chairside visits and building relationships. His job is simple—keep doctors happy and keep them coming back. And he couldn't do it without iCortica. Right from his phone, Elvis can see sales, remake rates, account notes, risks, and cross-sell opportunities—even before he walks through the door. No spreadsheets. No surprises. Just the info he needs to grow accounts. Stop digging for data and start taking action. Head to icortica.com and schedule your demo today. Join us at exocad Insights 2026, happening April 30–May 1, 2026, on the stunning island of Mallorca, Spain. This two-day event features powerhouse keynotes, hands-on workshops, live software demos, and top-tier industry showcases—all in one unforgettable setting. Barb and Elvis will be on site bringing you exclusive interviews, plus don't miss the FIRST 5k run on the coast! And of course, cap it all off with the legendary exoGlam Night under the stars. Tickets are limited. Visit exocad.com/insights-2026 and use code VFTBPalma15 for 15% off. In today's dental labs, reliability isn't optional—it's essential. That's why so many labs trust Roland DGSHAPE milling solutions—true workhorses known for precision, durability, and dependable performance day after day. Now Roland is taking digital denture production even further with the Elevate Denture Solution, including compatibility with Ivotion Denture System from Ivoclar. This validated workflow gives labs a powerful way to produce premium digital dentures with confidence and consistency. Built on the trusted DWX milling platform, the Elevate Denture Solution allows labs to expand their capabilities while continuing to rely on the same dependable technology that keeps production running smoothly. Learn more about DWX Milling Solutions and the new Elevate Denture Solution at rolanddental.com.Special Guests: Andreas Klie, Don Bell, and Rob Fletcher.

Bach Artillerie is made up of multi-instrumental wizards Greg Saunier (Deerhoof) and Curt Sydnor. This absurdist take on the nine canons from Johann Sebastian Bach's Goldberg Variations and his Brandenburg concerto no. 5. will be released on April 24th via Ernest Jenning Records. We get a unique perspective from both Greg and Curt not only on Bach's musicality, but his work ethic, the root of his dissonance and why Bach has a grounding influence on their own music creation. They discuss how a Lutheran work ethic relates to music making today and why being less productive may be better for our species in general. Greg and Curt explain why it's important to “play tempo to the room”, they share their experience of making the record in one day and the three discuss why AI is more of an indication of a lack of trust rather than a lack of competence. Curt tells us how a re-arrangement of a Deerhoof song brought he and Greg together, we hear a new tune and somehow the topic of The Red Hot Chili Peppers sneaks into the conversation. Bach ArtillerieErnest Jenning RecordsOur newest sponsor Kingston Union is YOUR store for the legendary Winos.This episode supported by our friends at Izotope. This episode is produced with Ozone 12, the newest from Izotope. Head over to izotope.com now for savings on all their production software. Go check out Ozone 12 and RX 11 and master with the best and solve the unsolvable. Use code FRET10 at checkout.Ep supported by Distrokid . Distrokid now offers Bandzoogle where you can build your bands website and store in minutes. Tour stories listeners get 30% off at distrokid.com/vip/tourstories. GET YOUR MUSIC OUT THERE! ITS EASY WITH DistrokidEpisode sponsored by Schecter Guitars. Schecter Guitar Research is one of the world's premier guitar companies, offering electric guitars and basses, acoustic guitars, and USA Custom Shop instruments to musicians around the world.Its continually evolving and expanding line of guitars and basses appeals to a broad spectrum of players and diverse musical styles. They offer high-quality instruments with professional components at an affordable price. Go Schecter for all your guitar needsRuinous MediaOur newest sponsor Kingston Union is YOUR store for the legendary Winos.

Ever wonder why a complex gallbladder surgery only nets the surgeon about $350, while the hospital collects thousands? In this episode, Dr. Christopher Childers and Dr. Nina Clark pull back the curtain on how the money actually flows in medicine. From the birth of the RVU to the "Two Midnight Rule," we're breaking down the math behind your paycheck.Next Step: Ready to make sure you're actually getting credit for the work you do? Join us for Episode 3, where we dive into the "Black Box" of Coding and Billing. ***Fellowship Application Link: https://forms.gle/QSUrR2GWHDZ1MmWC6Sponsor Disclaimer: Visit goremedical.com/btkpod to learn more about GORE® SYNECOR Biomaterial, including supporting references and disclaimers for the presented content.  Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. Rx only Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

This week, Alex talks with Beck and Zac about a formative pair of BMWs in Zac's neighborhood growing up; a snowballed BMW project threatening to be come a full avalanche; a very quick turnaround; a curious Bay Area car-buying ploy; Alex's odd but steadfast list of cheap childhood cars he'd buy if only he could find them; (misplaced?) nostalgia for late-1980s Ford performance cars and keyless entry code buttons; and attainable transaxle Porsches.The team goes on to describe a brief history of the Toyota celebrity support race at the Long Beach Grand Prix; impressive feats from a 190E  2.3 16-valve; Gene Hackman's side gig; Tommy Kendall, an all-around decent guy; a good color change; an interesting museum collection sale; and current watchlist favorites punctuated with Porsche whale-tale nerdiness and shame.Mentioned in this episode:1:30  S52-Powered 1988 BMW M36:25  Pristine 69k-Mile 1990 BMW M315:16  4,700-Mile 1988 Ford Thunderbird Turbo Coupe15:52 19k-Mile 1989 Ford Taurus SHO17:42  37k-Mile 1988 Alfa Romeo Milano Verde17:56  1988 Alfa Romeo Milano Verde21:24  Mercedes-Benz C230 Kompressor Sport Coupes on BaT24:11  2000-2006 Toyota Celicas on BaT30:57  Mini R53 Cooper S Model Page36:27  IMSA, NASCAR, RX-7s, and Land Yachts with Tommy Kendall37:34  49k-Mile 1992 Ford Taurus SHO38:20  Original-Owner 1979 BMW M138:43  Ex–Stu Hayner 1989 Chevrolet Corvette Challenge Race Car38:54  The Gilmore Car Museum Collection, Offered at No Reserve39:17 Gilmore_Cars user page40:13  1993 Geo Tracker LSi 4×4 5-Speed w/Camso Track System40:55  1964 Ford Galaxie 500XL Fastback R-Code 427 4-Speed41:21  Euro 1986 Ferrari 328 GTB42:01 2023 Hennessey Venom F5 Roadster43:38  1968 Mazda Cosmo Series II43:42  1990 Lamborghini LM002 LM/American45:23 RoW 1974 Porsche 911 Carrera 2.7 MFI Coupe46:58  Whale Tales: A Visual Guide to the Evolution of Porsche 911 Spoilers47:26  Dual-Quad 350–Powered 1956 Chevrolet Bel Air 2-Door Hardtop Coupe47:37  MSCLASSICCARSLLC user page47:46 Bill Goldberg's Twin-Plug 1992 Porsche 911 Turbo49:55  RoW 1977 Porsche 911 Carrera 3.0 Coupe51:26  1975 Porsche 911 CarreraGot suggestions for our next guest from the BaT community, One Year Garage episode, or (B)aT the Movies subject? Let us know in the comments below!

Andrew Billingsly, CEO at Plaswire, joins to discuss how the company recycles wind turbine blades into construction materials, timber replacements, and utility products. Plus carbon fiber recovery, zero-dust cutting technology, and plans to license blueprint factories worldwide. Sign up now for Uptime Tech News, our weekly newsletter on all things wind technology. This episode is sponsored by Weather Guard Lightning Tech. Learn more about Weather Guard’s StrikeTape Wind Turbine LPS retrofit. Follow the show on YouTube, Linkedin and visit Weather Guard on the web. And subscribe to Rosemary’s “Engineering with Rosie” YouTube channel here. Have a question we can answer on the show? Email us! Andrew Billingsly: Exactly.  Allen Hall: Are we good?  Andrew Billingsly: I’m truly impressed with this great operation you’ve got. You really moved this forward, isn’t it? That’s great. We try. Yeah.  Allen Hall: Yeah, we try. We’re not  Andrew Billingsly: trying. You do.  Allen Hall: So I, I will put an intro to this episode when we get back to the states. So I’m just gonna say, Andrew, welcome to the show. And then we will start talking.  Andrew Billingsly: Where do I look  Allen Hall: here?  Andrew Billingsly: Right? Just, just here.  Allen Hall: Yeah. Don’t worry about those. We’ll figure that out later. That’s,  Andrew Billingsly: yeah. A bit of AI in that. Yeah.  Allen Hall: Yeah.  Andrew Billingsly: And you’ll see as well. Andrew, welcome to the program. Thank you very much, Alan. Joe, really great pleasure to be here today.  Allen Hall: So we’re here to learn about PLA wire and all the great things you’re doing in Northern Ireland because you’re involved in a lot of recycling efforts in wind, outside of wind. You’re doing very novel things, which I think the world needs to hear about. Let’s just back up a minute, because not everybody. And particularly [00:01:00]in North America has heard of PLA wire, even though you, you’re all over LinkedIn. What does PLA wire do? What is this basic fundamental of PLA wire?  Andrew Billingsly: Basically, we’re a processor of polymers. Okay?  Andrew Billingsly: So that’s how we see ourselves, that’s how we frame ourselves. We’re a polymer processor with a waste management license. Uh,  Joel Saxum: I think the important thing here, and this is why I wanted to have this conversation, you and I have been talking in the background for a few years, is. The rhetoric around a lot of the world is we have this problem with recycling blades. We can’t figure it out. Nobody’s got any solutions. Um, and if they do, it’s very agricultural as we say, right? They’re just grinding them up, using ’em in this, that, and what I tell people is like, no, no, you’re incorrect here. There are people doing this. There is, there is solutions out there. It just needs to be, we need, we need to talk about it. We need to put it out there.  Andrew Billingsly: Absolutely. Uh, I fight very hard to tell the true story. Of course, there’s a [00:02:00] lot of greenwashing in every sector of every industry in the world, and those who do it right have to defend themselves. I mean, unfortunately, that’s what we have to do. Fortunately, mostly we’re able to do that if we work hard at it. For us, we do not have a problem in general, dealing with wind farm waste. Wind farm waste is for us blades. Because we’ve taken a pragmatic approach to it. We have to look at how we deal with any waste coming into our, uh, process to ensure it’s environmentally handled, that it’s handled correctly, environmentally, that it meets a price point so that whatever we do with it, we can sell that product, ensure that it’s sustainable in how we operate, and it’s fully circular. So that’s how we’ve addressed wind blades. We were invited into the industry and we worked out what was needed in the industry. But [00:03:00] before we went all full on with it, we had to make sure we could make products that was saleable, that was usable, and could be utilized within the industry wherever possible. But you thought outside of the box  Allen Hall: quite a bit because the way I think the wind turbine blade recycling efforts have gone is to say, well, we’ll, just like Joel was saying, we’ll just grind them up. You’re taking polymer outside of the wind blade world that you’ve been using in aerospace and other industries and saying the valuable part of the wind turbine blade is the fiber and the resin, whatever remains there. If I combine that with other polymers, I can create products with a lifetime that can replace other more expensive items, metal items, cement items. That is the, the, the wisdom that went into what you have done. How did you come up with that?  Andrew Billingsly: I think I was born outta the box. Frankly. I’ve been told that several times.[00:04:00] We’re a solution orientated company. Uh, I was talking recently to somebody about how we built our first factory in Northern Ireland that went up in 10 weeks. That’s 20,000 square feet. And because the pressure we were under, we had that factory erected and in operation in 10 weeks. And that’s just a fact. That’s a recorded fact. And I looked back only two years later and said, heck, what did we do there? Yeah, because we had to do it. So we did it. Yeah. We looked at the problem with the wind blade and we thought, we’ve gotta get a good solution for this. And we’d done that years before with aviation. We were presented with the challenge to deal with plastics arising from the manufacturer’s seating. Now the US produces all the plastics for that sector. It comes into Europe for manufacturing seats, a lot of it local to where our factory is, but nobody had a solution. I have to put my hands up now. I broke a few rules here. I filled two [00:05:00] barn up with this material chopped up and ready to sell, but I actually couldn’t sell it, but I knew there was a solution. So I worked on that for perhaps 18 months and then it worked. And today we are the main, uh, processor of this plastic that comes out of aircraft seating manufacturing, possibly. We still are the only one doing that.  Allen Hall: So you actually take the plastics from the manufacturer of seating and there’s a lot of scrap that’s involved in that. Andrew Billingsly: Yep.  Allen Hall: You take all that plastic waste, you bring it back into your facility, you recombine and pelletize it again so that it can be reused somewhere else.  Andrew Billingsly: Yes, that material goes into, uh, an extrusion process with another company now. Okay. Wow.  Joel Saxum: But, but that’s the same thing you’re doing in wind right now, right? The making it circular, but you’re adding or you’re, you’re adding other second use plastics to it.  Andrew Billingsly: Yeah. So our outta the box thinking was looking back in 2018, how do we grow our business [00:06:00] because recycling plastics within the extrusion world and the injection molding world. What’s getting more internal companies getting better at dealing with their own waste and putting it back into the circuit. So what’s the waste? Nobody wants. It’s the really mucky stuff. It’s this material that comes out of, for example, bio digesters that take the supermarket garbage, the yellow label food that people don’t buy because it’s really is in a bad state. And that goes for digestion and they pull outta those biodigester 10% plastic waste. Hmm. That is a really difficult product to deal with. And not only that, you also find a similar volume of waste coming maybe 24 tons a day, in some cases, sometimes more from the municipal waste processing centers as well. All this waste plastic goes for incineration. Nobody knows how to economically recycle that. So we took on that challenge and produced what we call [00:07:00] RX polymer, which is. Hm, going through pattern now. I got the number only yesterday incidentally for it. And, uh, this enables us then to combine plastics that would not normally combine. So think about polyethylene, polypropylene. Yeah, they mix, but then add in nylon, adding polyester. PET, add in styrene, adding up to 8%, uh, PVC materials. It’s an unknown for a polymer engineer, but we did that. And we cooperated with the university in Ireland to prove it. Uh, this is the technology Uni University in Shannon, and we still have an extremely good relationship with them. So we have this polymer. Along comes COVID, we worked with it. We did the deep dive. We went out to find out could we make product with it, could we make a product people wanted, and could we sell that product because what’s the point otherwise? And then after COVID. [00:08:00] We went out into the market, met with aviation, had a very substantial and transformative almost meeting with Paul Bella, director at Boeing. So by the end of the year we’d worked out along with some discussions with Air Airbus and with Tarmac Aero serve, how we could help them with their composite wastes as part of our RX polymer January, 2023. We got sucked into a, into the wind sector.  Allen Hall: Mm-hmm.  Andrew Billingsly: January, 2023. We got sucked into the wind sector with a significant phone call from Ted. We had a meeting and agreed to take their first blades. We went out bo more land and that was start of a journey.  Allen Hall: Okay. So it just calls you up and says, Andrew, I need you to start recycling our offshore, mostly offshore or all offshore blades.  Andrew Billingsly: These were initially on shore blades. On  Allen Hall: shore blades. Okay. Andrew Billingsly: And they said, did we know how to do it? Could [00:09:00]we do it?  Allen Hall: Okay?  Andrew Billingsly: And we said, yes.  Allen Hall: You said that? Yes. Without really knowing if the answer is yes.  Andrew Billingsly: Yes.  Allen Hall: Okay. I, I think that one of the things, I’m gonna back up just for a minute here. One of the things about Northern Ireland that people in the states don’t really realize is plastics and ejection molding are a focal point for Northern Ireland. Roy, which is the big plastic comb. Brush manufacturer is based in Northern Ireland, so there’s a tremendous amount of plastic knowledge, injection molding knowledge sitting right in the same area. So hearing your story just makes me think, yes, this all starts to make sense now that, that the whole region is a, uh, epicenter in it, so to speak, of how to think about plastics working with shorts and bombardier and all the now Airbus and Boeing. Those people are brilliant and you’re cut off the same limb of the tree. Right. [00:10:00] Where are these products now being used? So you now you’re getting blade from Wared and you, well, let’s talk first.  Andrew Billingsly: You have other customers besides Wared now you have some big names there. Oh, absolutely. So we do work with Airbus. We do work with Boeing on the aviation side, but we’re talking wind today. Uh, so we have Sted, we work with Eola, Scottish Power Renewables, work with GE Verona. RWE uh, a host of them actually just goes on and on, you know, and it’s very important to serve these companies as best we can. Uh, we’ve recently started working with EDF and taking first fleets from a lot of these first fleets of blades from these companies. We have a contract with BNM, which is in partnership with Ocean Wind for the future. BNM is B and Owner one of those great stories of a dirty company in the sense of producing. Fuel for, uh, households from Pete, which is extremely smoky and so forth, transforming to being the best [00:11:00] when it comes to, uh, renewables in Ireland. Wow. Wow. Yeah,  Joel Saxum: I didn’t even know you could do that. Make fuel out of Pete. I just knew you made whiskey out of it. My knowledge is not as good as your, your knowledge. Uh, but so questions for you. Then you have all these other customers coming in. You’re bringing in plastics from other areas and other sectors. How many right now as it sits, how many wind blades can you guys run through, you think? What does a yearly put throughput look like? So  Andrew Billingsly: when we get to capacity as we grow the business, we’ll be able to process up to 11,000 tons of blades on our site.  Joel Saxum: Okay.  Andrew Billingsly: Whoa. Which is a good size capacity. Yeah. Uh, far, far in excess of what we expected, but that was to do with development. We moved from putting 10% blade into our finished product to 30%. Joel Saxum: Yeah.  Andrew Billingsly: It was a big step. We achieved that in March this year, and it was just a. Happy days. And,  Joel Saxum: and when we talk product, right, we’re talking the RX polymer, but what is the end product? What can that be used for?  Andrew Billingsly: So the end product, uh, we can directly [00:12:00] replace virgin plastics in certain situations in the construction industry. Things like protection board, shuttering board and that type of thing. For, uh, precast concrete, there’s a lot of precast concrete products are manufactured because it’s easy to do with, uh, concrete and to use virgin plastics. It’s just not even thought of doing that. But with our RX polymer and the combination of a fiber base in it, we can produce precast concrete products, which outperform concrete versions. We’ve now got a polymer version, which won’t crack through temperature, variation through vibration, through wet and dry cycling, that type of thing. Wow. It’s kind of no brainer in a sense. And then on the timber replacement,  Joel Saxum: scour protection, offshore wind.  Allen Hall: There’s certain, well being in Northern Ireland, there’s a lot of wind and rain and sea and all the above. Oh yeah. It’s  Andrew Billingsly: plenty of all of those. There it is. Definitely. It’s just wet and a bit like Glasgow, plenty of rain, you [00:13:00] know, and or Seattle’s not so different actually. It’s sure. Very similar. It could be quite similar. Yeah. So, and timber replacement is a big thing because the supply of timber cannot meet demand. Yeah. To try and accelerate the supply of timber. They accelerate the growth of the trees using hydrocarbons in the form of fertilizers. And it’s not really gonna go anywhere in the right way. But to be able to put out product now, which outperforms timber for the utilities is a logical step for us. And that’s what we’ve done. Producing poles and posts, which are fiber reinforced, which outperformed timber for the utility companies. Just one design by one utility in the UK consumes 33,000 tons a year. It is madness. I know. But we can offer them a product which lasts a minimum of 30 years certified versus a timber version that because of the regulations regarding, uh, preservatives, it could only last between eight and 10 years. Allen Hall: Oh, [00:14:00] sure. Well that makes a lot of sense. So you’ve, you’ve broken through the barrier of blade recycling into now almost consumer products, industrial products, construction products. Uh. What’s next? Where are you going next? You gonna start making airplanes and cars out of this material or  Andrew Billingsly: no? That I fell outta the box actually bumping my head so I can’t go any further. Um, where do we go from this Look, we are always going to be looking to be better at what we do, so on the blade side, we have great cutting technology that everybody should look at and consider doing something at least similar. So no dust. Very important, and we are moving sometime next year. We haven’t got a date for this yet, where we’ll have a robotic cutting system with absolutely no ze, no dust at all. Zero dust. That’s amazing. Yeah.  Joel Saxum: That’s a, that is a, that’s a big problem in like the states for plane recycling. The, the [00:15:00] regulations around dust and um, and how close you can be to residential areas and siding and all those kind of things.  Andrew Billingsly: If you’re making dust and it’s landing on the ground, it’s gonna be there forever. So don’t make it.  Joel Saxum: There you go.  Andrew Billingsly: That’s the fact. Um, the idea of the robotics is also to be able to recover the carbon fiber, stay in the center of the blade.  Joel Saxum: Yeah. ‘ Andrew Billingsly: cause carbon fiber is heading towards being a shortage product. And we have the opportunity to preserve that and re reuse that product effectively. If you see the carbon fiber in a blade and the big blades, 70 meters and so forth, you go, wow, it’s pencil thickness. You don’t want to see that getting weight.  Allen Hall: Right.  Andrew Billingsly: So using expensive  Allen Hall: too. Yeah.  Andrew Billingsly: Using, yeah, it’s very expensive. Get more so, you know, we are using carbon fiber for novelty. Things like fass in cars and so forth, right. Or wrongs and other matter. But it’s utilizing a product that needs to be going into better applications. No doubt about it. So we’re going in that way to improve the cutting technology. And then [00:16:00] another area is a recyclable blade. So we are talking with the developers of the original recyclable Blade technology about should we be working with them to operate a facility to enable that future technology to become operable. It’s okay to sell the product, but are you recycling it afterwards?  Allen Hall: Right. Can you break it down and get the fiber out of it? Yeah.  Andrew Billingsly: So they’re early discussions and we’d like to progress those over time and achieve a success for everybody there.  Joel Saxum: So Audi, the, the, the facility in Ireland, you’re doing a lot of process improvement. You’re getting better and better and better, but you can, you can process a certain amount of tons there per year. Are you looking at mainland Europe, US South America? Are you, are you moving around yet or,  Andrew Billingsly: yeah. You are a mind reader, aren’t you? I think. Come on now. Look. So we are working with the crown estate. I don’t know, how do you know about the crown estate? Very, uh, influential party, uh, regarding offshore wind [00:17:00] and onshore wind. Okay. And we are working on a feasibility study with them to create a blueprint factory and put up a new facility in the United Kingdom in Scotland. Where we put, that is still under negotiation at the moment because it depends whether or not there’s gonna be a blade manufacturing facility there. Blade manufacturing waste has to be dealt with. Oh yes, it has to. And it’s been ignored and it has to be dealt with and we align to be doing that.  Allen Hall: So you would set up shop next door to the blade manufacturing facility.  Andrew Billingsly: That’s the optimal thing to do.  Allen Hall: Sure it  is.  Andrew Billingsly: Yep. And there’s various discussions taking place with more than one manufacturer about putting a facility into Scotland, but I’m not privy to discuss those things. And then in England, working with a consortium to put up a facility there which will support the offshore wind as it decommissions.  Allen Hall: Oh sure. Wow. See, we have a lot of plans. Yeah. For  Andrew Billingsly: the future. Yeah. And we real, we will realize them. Uh, the beauty of all of this [00:18:00] is the carbon saving because we are diverting products away from incineration. And if you take a blade and put into cement kilt, you’re still producing CO2.  Allen Hall: Sure. It  Andrew Billingsly: has to. And we know that’s not a long term solution because when you melt glass, glass sinks to the bottom of the furnace and one by one cement kiln say, we’ve had enough of this and it seems to affect the refractory bricks as well. Which causes deterioration and another cost for the cement companies. So we can prevent between 2.7 and 2.9 tons of CO2 production. For every ton of waste we divert from this generation.  Allen Hall: Wow. That’s tremendous.  Andrew Billingsly: That’s tremendous. Yeah. And then the products we replace in the market, the virgin plastics, the precast concrete replacements, the, the timber replacements all have high carbon numbers, but now that’s finished. Right. Yeah. So we can net up to 1.7 tons of CO2 offset saving, [00:19:00]whatever way you want to put it, for every time we process. That’s quite fantastic. Well, now we never knew these numbers. As I say, we were pulled into this industry and then we started to look at what are we doing here? And whoa, we didn’t realize. Joel Saxum: Fantastic.  Allen Hall: Well, for, for everybody who’s listening today that deals with blades and that, that’s a vast majority of our relationship has to do with blades somewhat during their life cycle. And I’m wondering what the next generation of recycling actually looks like. It’s PLA wire and they need to get a hold of you, Andrew. How would they do that? To learn more?  Andrew Billingsly: Yes. Well, we are talking with potential partners. Our way to grow is really through a licensing system.  Allen Hall: Okay.  Andrew Billingsly: A reasonable licensing system. So our intention is to put out this blueprint factory, which can be manipulated to suit the market. It can be smaller, it can be larger. The equipment for it is standard. It’s a lot of standard machines joined together in a particular way. The keys and the process and so forth. [00:20:00] So for example, we can offer a blueprint to a company and they equip it with US machinery or Mexican machinery or whatever, machinery. Sure. Yep. So they can control the cost of that. So we sell that design, sell them the engineering work to it. Work with ’em on their market surveys in advance to make sure they’re not going into a world that’s not gonna produce revenue for them. Everything has to be profitable. Assure them of the markets for the finished products, and then work on a license fee with them. Allen Hall: Okay. And they can do that by going to the website PLA wire. You can just Google PLAs Wire,  Andrew Billingsly: Google. Yeah. So you’ll find me at andrew@plaswire.com, which is easy enough for everybody, I believe. Yeah.  Allen Hall: P-L-A-S-W-I-R-E. Dot com.  Andrew Billingsly: That’s correct, Alan. Yeah. Thank you.  Allen Hall: Yeah, it’s a, it’s a really interesting website and Andrew, I’m really glad we had the time to sit down and to discuss your business because it is fascinating. It’s next generation on recycling, and it’s good to spread the word a little bit. So thank you for [00:21:00] joining us today,  Andrew Billingsly: Alan. Joel. It’s been really good for me too. It. I’m so pleased to be able to do this. Yes. And you know what you want the most fantastic podcast to listen to, I have to tell you that. Yeah. Allen Hall: Well we need to have Yon Moore. So  Andrew Billingsly: yeah, I’ll be very happy and love to be able to share our progress as we develop and just, we are always gonna be a changing organization, but always for the better. And you’re gonna understand, I guess we’re quite passionate about what we do.  Allen Hall: Yes.  Andrew Billingsly: Yeah.  Allen Hall: Yes. Congratulations and thank you for joining us.  Andrew Billingsly: Thank you very much. Yep. Perfect. Cool. Wonderful. Wow. So easy now.

If Dylan wants another week to think, Dylan gets another week to think. We will instead see what the dice have in store... and oh, it's a dead end! Well, that's fine. The Wuxia is cool, and we have other things to talk about besides. You can find a video version of this podcast for free on Scanline Media's Patreon! If you want to find us on Bluesky, Dylan is lowpolyrobot.bsky.social and Six is six.scanlinemedia.com. Our opening theme is the Hangar Theme from Gundam Breaker 3, and our ending theme for this episode is Resumption from Gundam Breaker 4. Our podcast art is a fantastic piece of work from Twitter artist @fenfelt. Want to see a list of every unit we've covered from every episode, including variants and tangents? It's right here. The Scanline Media Discord can be found here! Units discussed: CAMS-04 Wuxia XM-X1 Crossbone Gundam X-1 (Marine Houshou Ver.) ZGMF-X10A Freedom Gundam (Koyori Hakui Ver.) RX-0[N] Unicorn Gundam 02 Banshee Norn (Chihaya Rindo Ver.) GN-001 Gundam Exia (Fubuki Shirakami Ver.) RX-93 ν Gundam (Miko Sakura Ver.) MSN-04 Sazabi (Suisei Hoshimachi Ver.)

In this episode of Let's Combinate, Subhi Saadeh speaks with Jen Riter about analytical method validation for drug device combination products. The discussion explores how traditional drug analytical validation under ICH Q2 differs from validating functional and mechanical performance methods used for combination products. These methods often require an engineering mindset that incorporates measurement system analysis (MSA), gage R&R studies, and the use of fabricated surrogate standards when devices cannot be reused for testing.They also discuss platform test methods and how standards such as ISO 11040 and other ISO references can serve as starting points for method development. The conversation touches on the evolving alignment between ISO based device methods and pharmacopeial expectations such as USP . The episode also covers make vs buy testing decisions, when to outsource specialized testing such as CCIT and extractables and leachables, and how sponsors manage oversight of contract testing laboratories.Timestamps00:00 Welcome and Guest Introduction00:53 ICH Q2 vs MSA Mindset Shift04:37 Surrogate Standards for Mechanical Testing11:12 Platform Methods and ISO 1104015:14 ISO vs USP Verification Debate20:06 Outsourcing Analytical Testing Strategy24:07 Choosing the Right Test Lab26:20 Sponsor Oversight of Contract Labs30:09 Wrap UpAbout Jen RiterJen Riter is an analytical testing and laboratory leader with nearly three decades of experience working in pharmaceutical packaging, drug delivery systems, and combination products. She has held leadership roles at West Pharmaceutical Services and Kindeva Drug Delivery, where her work has focused on analytical method development, validation, and testing strategies for drug delivery systems and injectable combination products. She is also a contributor to the Combination Products Handbook, where she authored a chapter on analytical testing and method validation for combination products.About Subhi SaadehSubhi Saadeh is the Founder and Principal of Let's Combinate BioWorks, where he helps companies close the gaps between drug and device development, quality systems, and regulatory expectations. He is a Certified Quality Auditor and ISO 13485 Lead Auditor with leadership experience at Baxter, Pfizer, and Gilead Sciences including responsibility for management and oversight of assemble label pack sites and working with device primary, secondary and tertiary packaging suppliers. Subhi previously chaired the Combination Product Working Group for Rx-360, served as International Committee Chair for the Combination Products Coalition, and served on AAMI's Combination Products Committee. He also hosts the Let's Combinate podcast and is a writer and speaker on quality at the intersection of drugs and devices.

Welcome back to our special season bringing you the best sessions from the Definitive AI Forum for Media, Information and Events, which we held with Flashes & Flames in London. This week we're featuring a panel looking at whether AI is a golden opportunity for exhibitions and events organisers. This featured Greg Hitchen, CEO of Terrapinn, Alison Jackson, Group MD at Nineteen Group, Robin Booth, Managing Director at EMAP, and Robin Tapp, CIO at RX, interviewed by Flashes & Flames' Colin Morrison. The panel discussed AI's role in enhancing face-to-face interactions and improving efficiency, as well as its use in revenue generation, leveraging metadata, and matching buyers and sellers.  Read the key takeaways from this session, find our weekly newsletter, AI Masterclasses and more on voices.media

Alex Edkins is a singer, song writer and guitarist for Weird Nightmare, Noble Rot and Metz. The newest Weird Nightmare album Hoopla is out May 1 via Sup Pop Records and is the quintessence of power pop punk rock and roll. Alex tells us why the new record leans into a more direct and fun approach and where his love for power pop began. We learn how his lyrics have moved to a more personal delivery and why Hoopla is in many ways a sentimental and reminiscent journey. Alex share's how his song writing and level of effort for Weird Nightmare differs from the dissonant riffage of Metz and why he sees Hoopla as an overall serendipitous experience. Joe and Alex share their love for producer Jim Eno, discuss the “twofer” nature of the Hoopla and we sample a couple new tunes.Weird NightmareSub Pop RecordsThis episode supported by our friends at Izotope. This episode is produced with Ozone 12, the newest from Izotope. Head over to izotope.com now for savings on all their production software. Go check out Ozone 12 and RX 11 and master with the best and solve the unsolvable. Use code FRET10 at checkout.Ep supported by Distrokid . Distrokid now offers Bandzoogle where you can build your bands website and store in minutes. Tour stories listeners get 30% off at distrokid.com/vip/tourstories. GET YOUR MUSIC OUT THERE! ITS EASY WITH DistrokidEpisode sponsored by Schecter Guitars. Schecter Guitar Research is one of the world's premier guitar companies, offering electric guitars and basses, acoustic guitars, and USA Custom Shop instruments to musicians around the world.Its continually evolving and expanding line of guitars and basses appeals to a broad spectrum of players and diverse musical styles. They offer high-quality instruments with professional components at an affordable price. Go Schecter for all your guitar needsRuinous MediaOur newest sponsor Kingston Union is YOUR store for the legendary Winos.Club SawThree Penny OperaHaydenNoble RotSpoonJuliana RiolinoRed CrossBuzzcocksRobin HitchcockCleaners from VenusUndertonesOasisMentioned in this episode:DistrokidIzotopeSchecter Guitars

We break down the new Open workout and show you how to choose RX or scale, pace the lunges and snatches, and arrive at the final gymnastics with confidence. Mobility, mindset, and smart reps-per-minute planning turn a chaotic test into a clear plan.• choosing RX or scale using a two‑thirds rule• leaderboard quirks and why stimulus matters• scaled path realities for jumping and strict pull limits• overhead lunge mobility and non‑alternating rule• universal pacing to protect final gymnastics• reps‑per‑minute math and scorecard details• tiebreak trade‑offs versus total reps gained• mental game for failed attempts and confidence• warm‑up that simulates fatigue and counts stepsBe on the lookout for next week's episode

On this episode of Astonishing Healthcare, Lloyd Fiorini, General Counsel & Chief Compliance Officer at Judi Health, returns to the studio for a discussion about the barrage of regulatory changes shaping the pharmacy benefit manager (PBM) landscape in early 2026. Within just two weeks, the Department of Labor announced new proposed rules, the Consolidated Appropriations Act of 2026 became law, and the FTC's announced a settlement with Express Scripts. Then, to top it all off, TrumpRx went live.Lloyd offers clear, helpful explanations of the key takeaways from each of these concurrent reforms aimed at improving transparency and how PBMs operate and interact with the other stakeholders in the supply chain, from independent pharmacies to patients and plan sponsors (employers). Whether you're responsible for a self-funded plan or overseeing a Medicare Part D plan, this episode provides the detail and insights about where the puck is going that you need. As Lloyd said, "I think we've made a great step forward, but the work isn't done."It's also worth giving a shoutout to previous guest Jim Winkler, as "Change is Imminent" is in the title of AH090!Episode HighlightsThe Department of Labor's historic proposed rules on PBM disclosures fills a gap left by the CAA of 2021The Consolidated Appropriations Act of 2026 redefines the financial alignment of pharmacy benefits beyond just Medicare Part Patient/plan member protection seems to be what the FTC's recent settlement was all aboutTrumpRx signals a broader shift toward transparent, cost-plus pricing models, but it's just for cash-paying customers, at least for nowDelinking and efforts to block vertical integration are hotly contestedRelated ContentAH095 - What's in Store for the New Year? A Special Round-Robin Episode of Astonishing HealthcareHow to obtain Rx data and what to do with itAH096 - A Quick Government Programs Update: The IRA & MPPP, Managing D-SNPs, and More, with Jason BarrettoSigns it is time to change your PBM vendor, and how to overcome common hesitationsReference LinksUS Department of Labor proposes historic pharmacy benefit manager fee disclosure rule (January 29)PBM Reforms Signed Into Law, Reshaping Medicare Part D Drug Pricing Transparency (February 3)FTC Secures Landmark Settlement with Express Scripts to Lower Drug Costs for American Patients (February 4)TrumpRx Launches (February 6)For more information about Judi Health and this episode, please visit Judi Health - Insights.

CC466: In today's episode, Lindsie takes a moment to address reports of her death (again!). A moment of silence...ANYWAYS! The ladies dive into a series of true crime updates, such as the ongoing Lindsay Clancy trial and Apalachee High School shooting trial. The ladies react to the Teen Dad TikTok saga involving a 12-year-old and a 15-year-old. Kail shares some BTS insights on the early days of 16 and Pregnant - discussing the original pay structure and the lack of royalties in the streaming era. Lastly, for today's Foul Play, a listener shares a WILD betrayal involving an ex-husband, Craiglist and a major breach of trust in the bedroom.Thank you to our sponsors!Better Help: This episode is brought to you by BetterHelp. Visit BetterHelp.com/coffee today to get 10% off your first month.Fabletics: Head to Fabletics.com/coffeeconvos, take a quick style quiz, and be sure to select coffeeconvos when prompted to unlock your 80% off everythingProgressive: Visit Progressive.com to learn more!Rocket Money: Cancel unwanted subscriptions by going to RocketMoney.com/COFFEECONVOSRoBody: Find out if you're covered for free at Ro.Co/COFFEECONVOS. Rx only.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Our episode this time we're discussing how Lalah Sune was a young woman who may very well have become a mother to me, Char's Counterattack (1988) Mechs discussed: RX-93 ν Gundam MSN-04 Sazabi A ton more! All images: on our website. You can find Stephen Hero on the GRFM Bluesky and on the Mech-a-Day Bluesky Content warnings for this episode: [Ecological Genocide, Warfare, Child soldiers, Mental anguish and abuse.] On the Shoulders of Giants is hosted by Alice (she/her), Brian (he/they), and Niko (she/her). We have an obligation-free tip jar on Ko-Fi. Join OSG's Discord here. We stream on Twitch! You can find us on Bluesky @osgpod, YouTube @osg_pod, and Tumblr @osg-pod as well. Visit our website at osgpod.com and send questions/feedback to questions@osgpod.com. The intro theme for the One Year Pod is “Romantic Legends” by PartyFactor. Other royalty-free sound effects also sourced from Pixabay. If you've read this far, please consider leaving us a 5-star review on your podcatcher of choice. It really means a lot!

The Derm on RheumNow podcast is a collection of Citations and Content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, other CTD skin disorders. dermatology drugs, biiologics, JAKs - their use, efficacy and side effects.  Features Dr. Jack Cush, Editor at RheumNow.com.  SHOW NOTES FDA sent a complete response letter to AstraZeneca on their application (BLA) for anifrolumabs (Saphnelo) subcutaneous use in SLE. Despite a positive TULIP-SC trial & EU approval of SC-anifrolumab, FDA & sponsor still have to work things out. CRL reasons are unknown https://t.co/3dNwEyolrj Review of Calcinosis Cutis - Surgical intervent. most effective (excision, curettage, laser ablation, etc). Medical measures inconsistently, partially effective, best if used early & localized (CCB, TCN, probenecid, immunomodulation, biologics, colchicine, NA thiosulfate, & JAKi https://t.co/rv0hQBv6nX Systematic Review of Targeted Rx for Systemic Sclerosis: from 32 RCTs & 2036 pts Rx w/ 23 targeted agents. Guselkumab had greatest effect on mRSS, followed by tofacitinib, inebilizumab, & baricitinib. For FVC, B-cell Rx (belimumab, RTX) had highest efficacy https://buff.ly/vHOSRws Dermatomyositis outcomes w/ 2475 pts (claims) & 1196 pts (EHR). Half had myositis panels & 35% had + MSAbs. Steroid use common in 69% & 74%. HCQ, MTX, MMF. Outocmes (per 1000PYs) wereL all-cause hospitalisation 92, malignancy 15.3, ILD 6.4, and myocarditis 2.1 https://t.co/DJqKGNGX76 Danish DERMBIO registry of psoriasis pts Rx w/ biologics. Among 3790 bionaive pts ustekinumab had best 1-5 yr survival vs (ADA & SEC). In 3403 bioexperienced pts, bimekizumab, guselkumab, & risankizumab had highest 2-year drug survival rate. https://t.co/TInyLPMYkb Real-world study of 1202 #PsA pts shows that secukinumab retention rates were lower w/ smoking (79%/73%/72% in never/former/current smokers) but not w/ obesity (72%/77%/77% in normal/overweight/obese), Adh HR signif. higher w/ former (1.32) & current smokers (1.27)   https://t.co/1REWmod73W Together PSO Trial - Combination Ixekizumab and Tirzepatide Today Lilly announced top line results of the TOGETHER-PsO open-label, Phase 3b trial demonstrating the significant benefits of concomitant ixekizumab (IXE: an IL-17A inhibitor) and tirzepatide (TIR: GLP-1agonist) over https://t.co/YWCjN2NyGM

Austin Brose is the percussionist, drummer, and a founding member of The Nude Party. Their newest record, Look Who's Back” is out now just ahead of an extensive North American tour. Austin shares the origin of The Nude Party, the inseparable and nomadic nature of the group and why he thinks learning to play their instruments together has forged a healthy evolution of song writing. He tells us why the band landed in Joshua Tree to make the new record, how 70's NYC and glam rock may have seeped into some of the recording, and he shares a wild and shirtless studio moment. The two drummers dig into Austin's approach to tracking percussion and his experience of moving to the drum kit after 10 years as the percussionist. Austin hips Joe to a performance of the national anthem on congas and we hear a couple bangers from Look Who's Back.The Nude PartyThis episode supported by our friends at Izotope. This episode is produced with Ozone 12, the newest from Izotope. Head over to izotope.com now for savings on all their production software. Go check out Ozone 12 and RX 11 and master with the best and solve the unsolvable. Use code FRET10 at checkout.Ep supported by Distrokid . Distrokid now offers Bandzoogle where you can build your bands website and store in minutes. Tour stories listeners get 30% off at distrokid.com/vip/tourstories. GET YOUR MUSIC OUT THERE! ITS EASY WITH DistrokidEpisode sponsored by Schecter Guitars. Schecter Guitar Research is one of the world's premier guitar companies, offering electric guitars and basses, acoustic guitars, and USA Custom Shop instruments to musicians around the world.Its continually evolving and expanding line of guitars and basses appeals to a broad spectrum of players and diverse musical styles. They offer high-quality instruments with professional components at an affordable price. Go Schecter for all your guitar needsRuinous MediaOur newest sponsor Kingston Union YOUR store for the legendary Winos. Mentioned in this episode:IzotopeSchecter GuitarsDistrokid

Vince joins in on the Game commentary to focus on key player in the Maia: Mercury. We explore Mercury's role this year as psychopomp in water - slinging webs across realms, carrying reminders from depths otherwise out of focus, and doing the calculus level awareness computations. See the timestamps at the bottom of these notes for a focused look at each Mercury Rx period in 2026.2026 The Cosmic Context is offered in support of your meeting, embracing, digesting, and integrating everything you witness in your multidimensional inner & outer reality this year. May you do so with more presence and honesty than you ever have before.Join us to witness and digest in community throughout the year at quarterly ASCENDENT ASSEMBLIES gatherings where you can listen in on &/or contribute to expansive, collaborative dialogue with your elemental rising group. Enter the solarium at patreon.com/kelseyrosetort for access to these (live and recorded) gatherings and lots more.Places to Play:Find Vince at @pharmastrology on IG or via email at pharmastrology@gmail.com2026: The Cosmic Context Resources on Patreon (free)Attend Ascendant Assemblies by joining the solarium inside of the orbit field (don't join from your iPhone - it will cost way more!)For a ~free~ intro to 2027 & global cycles check out the "free" collection on the Orbit Field's patreonAnd/or go deep into 2027 study with Kelsey & Jessa via 2027: The BreakdownLearn Human Design via the Living Your Design Podcast (free)Check out Kelsey's other collaborative podcasts Lab Parters (free) and Quality Time (on patreon)Find Kelsey at kelseyrosetort.com and @kelseyrosetort on IG, or hit "join for free" on patreon to get updates and occasional invitations. (don't join a paid tier from your iPhone - it will cost way more!)timestamps for discussion on 2026 mercury Rx periods:1 hr 8 min | Mercury Rx in Piscespre shadow starts Feb 11

Formed in Yogyakarta, based in Jakarta, Grrl Gang is an Indonesian indie pop band consisting of vocalist/guitarist Angee Sentana, bassist/vocalist Akbar Rumandung, and guitarist/vocalist Edo Alventa. Their newest maxi-single release Online 24/7 is out now via Green Island Music. Angee and Akbar share the origin of the band and how The Stone Roses not only changed Akbar's life but played a role in the formation of the Grrl Gang. Angee tells us why her approach to the new songs is more direct and how their fans influenced this approach. She explains why she wanted to address the subject of femicide on the song O, My Love and why it was important to come from an empathetic perspective. The three discuss touring in Southeast Asia, the “guitarist personality” and we sample a few tunes from Online 24/7. Grrl GangGreen Island MusicThis episode supported by our friends at Izotope. This episode is produced with Ozone 12, the newest from Izotope. Head over to izotope.com now for savings on all their production software. Go check out Ozone 12 and RX 11 and master with the best and solve the unsolvable. Use code FRET10 at checkout.Ep supported by Distrokid . Distrokid now offers Bandzoogle where you can build your bands website and store in minutes. Tour stories listeners get 30% off at distrokid.com/vip/tourstories. GET YOUR MUSIC OUT THERE! ITS EASY WITH DistrokidEpisode sponsored by Schecter Guitars. Schecter Guitar Research is one of the world's premier guitar companies, offering electric guitars and basses, acoustic guitars, and USA Custom Shop instruments to musicians around the world.Its continually evolving and expanding line of guitars and basses appeals to a broad spectrum of players and diverse musical styles. They offer high-quality instruments with professional components at an affordable price. Go Schecter for all your guitar needsRuinous MediaKingston Union YOUR store for the legendary WinosMentioned in this...

On this episode of Astonishing Healthcare, Judi Health's Mike Tate (VP, National Business Development) and Mark Pearce (Director, TPA Operations) join us in the studio to discuss the role of Third-Party Administrators (TPAs) in the self-funded employer market. As Mike explains, TPAs act as the "enforcers" of an employer's plan document, responsible for pulling everything together and ensuring claims accuracy, network access, and financial stewardship. Mark dives into the distinction between carrier-owned (ASO) and independent TPAs, explaining how independent models offer greater flexibility in plan design. And of course, they highlight a significant industry challenge: legacy technology. Many administrators rely on antiquated systems that limit customization and data visibility. In contrast, modern platforms empower plan sponsors to integrate point solutions effectively, customize networks for high-value care (e.g., through centers of excellence), and drive better member engagement. If you've ever asked yourself, "What does a TPA really do?" or "Should I look at different TPAs?" this episode will be worth your time to listen to.Ultimately, successful healthcare administration relies on managing "hundreds of little things" correctly for each benefit (Rx, medical, vision, and dental) - from provider payments to member support. That's how you create positive financial and clinical outcomes. Related ContentAH080 - Health Benefits 101: The Importance of "Smart" Care Navigation, with Andy KageleiryReplay: The Future of Health Benefit Design: How Judi® Powers Seamless Care and Better OutcomesAH067 - Aligned Health Benefits and the Freedom to Unbundle, with Kristin Begley, PharmDJudi Health™ Earns Best Healthcare InsurTech Solution in the 9th Annual MedTech Breakthrough Awards ProgramFor more information about Judi Health and this episode, please visit Judi Health - Insights.

CC464: Kail flies solo this episode as Lindsie takes a day off. Kail addresses the flurry of fan questions regarding Kristen and her transition away from the podcast and business. She also reads from FB submitted Foul Plays that get a little unhinged.Thank you to our sponsors!Chime: Get started at chime.com/coffeeNurture: For 55% off your order, head to NurtureLife.com and use code CONVOS.RoBody: Find out if you're covered for free at Ro.Co/COFFEECONVOS. Rx only.SKIMS: Check out our favorite bras and underwear at http://www.skims.com/coffeeZocdoc: Go to Zocdoc.com/CONVOS to find and instantly book a doctor you love today!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Is this the sweet spot Lexus buyers have been overlooking?

Want a drive that actually feels like driving? We chart Texas routes that reward focus and finesse—FM 170 along Big Bend Ranch State Park with vast desert sight lines, the short-but-epic Palo Duro descent into red rock, Devil's Backbone across Hill Country ridges, the razor-tight Park Road 37 by Medina Lake, and the legendary Twisted Sisters with its switchbacks, blind crests, and breathtaking ranchland vistas. You'll get practical advice on when to go, what to watch, and how to prep so the only surprise is the view around the next bend.Then we flip the script and explore the wild side of automotive branding. Porsche's chef-level knives, Honda's quietly brilliant HondaJet, BMW and McLaren's high-end bicycles, Peugeot's heritage pepper mills, Toyota's loom-to-engine lineage, Mercedes' limited surfboards, and Bugatti's carbon fiber furniture show how engineering DNA travels from test tracks to kitchens, oceans, and living rooms. We dig into why these products make strategic sense—and where they're pure theater for the superfan.To ground it all, we share a hands-on review of the Lexus RX 450h Plus. The PHEV powertrain delivers smooth, satisfying acceleration and real-world efficiency, wrapped in a distinctive design that stands out from copycat SUVs. Inside, the minimalist cabin feels premium and calm, though we still want a few more physical controls for eyes-up driving. With up to 3,500 pounds of towing capacity, thoughtful packaging, and that excellent Mark Levinson sound, the RX 450h Plus competes credibly with the GLE and X5—especially if your routine fits the electric range sweet spot.If you're mapping a Hill Country loop, chasing bluebonnets, or just curious why a car brand would build a pepper mill, this episode brings the roads, the rationale, and the road test. Enjoyed the ride? Follow, rate, and share the show with a friend who needs a new route or a new knife—then tell us which Texas road is calling your name.Be sure to subscribe for more In Wheel Time Car Talk!The Lupe' Tortilla RestaurantsLupe Tortilla in Katy, Texas Gulf Coast Auto ShieldPaint protection, tint, and more!Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.---- ----- Want more In Wheel Time car talk any time? In Wheel Time is now available on Audacy! Just go to Audacy.com/InWheelTime where ever you are.----- -----Be sure to subscribe on your favorite podcast provider for the next episode of In Wheel Time Podcast and check out our live multiplatform broadcast every Saturday, 10a - 12nCT simulcasting on Audacy, YouTube, Facebook, Twitter, Twitch and InWheelTime.com.In Wheel Time Podcast can be heard on you mobile device from providers such as:Apple Podcasts, Amazon Music Podcast, Spotify, SiriusXM Podcast, iHeartRadio podcast, TuneIn + Alexa, Podcast Addict, Castro, Castbox, YouTube Podcast and more on your mobile device.Follow InWheelTime.com for the latest updates!Twitter: https://twitter.com/InWheelTimeInstagram: https://www.instagram.com/inwheeltime/https://www.youtube.com/inwheeltimehttps://www.Facebook.com/InWheelTimeFor more information about In Wheel Time Podcast, email us at info@inwheeltime.com

CC463: On this month's bonus episode... Lindsie and Kail share more stories on the complexities of co-parenting and the exhaustion of being the "default parent". They discuss the challenges of managing children's appointments, sports commitments, and the resentment that can build when responsibilities aren't shared equally. Also, a listener writes in to ask "Is It Cheating?" Thank you to our sponsors!Better Help: This episode is brought to you by BetterHelp. Visit BetterHelp.com/coffee today to get 10% off your first month.Little Spoon: Go to littlespoon.com/COFFEECONVOS and enter code COFFEECONVOS for 30% off your first orderQuince: Go to Quince.com/coffee to get free shipping and 365-day returns on your next orderRocket Money: Cancel unwanted subscriptions by going to RocketMoney.com/COFFEECONVOSRoBody: Find out if you're covered for free at Ro.Co/COFFEECONVOS. Rx only.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Join the Behind the Knife Surgical Oncology Team as we discuss the PRADO and NADINA randomized control trials regarding neoadjuvant therapy in Stage III melanoma with macroscopic nodal disease!Hosts:Timothy Vreeland, MD, FACS (@vreelant) is an Assistant Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist at Brooke Army Medical Center.Daniel Nelson, DO, FACS (@usarmydoc24) is Surgical Oncologist/HPB surgeon at Kaiser LAMC in Los Angeles.Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a 2ndYear Surgical Oncology fellow at MD Anderson.Beth (Elizabeth) Barbera, MD (@elizcarpenter16) is a General Surgery physician in the United States Air Force station at RAF Lakenheath.Joe (Joseph) Broderick, MD, MA (@joebrod5) is a General Surgery research resident between his second and third year at Brooke Army Medical Center.Galen Gist, MD (@gistgalen) is a General Surgery research resident between his second and third year at Brooke Army Medical Center. Learning Objectives:-       Evaluate the role of Completion Lymph Node Dissection (CLND) in patients with positive sentinel lymph nodes, specifically citing the lack of melanoma-specific survival benefit vs. the improvement in regional disease control demonstrated in the MSLT-II trial.-       Determine the appropriate surgical excision margins for primary cutaneous melanoma, comparing the outcomes of 1 cm versus 2 cm margins as analyzed in the MINT trial (Lancet 2019).-       Analyze the impact of adjuvant systemic therapy (Anti-PD1/Immunotherapy) on recurrence-free survival in patients with resected high-risk Stage III melanoma.References:Reijers, I.L.M., Menzies, A.M., van Akkooi, A.C.J. et al. Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial. Nat Med 28, 1178–1188 (2022). https://doi.org/10.1038/s41591-022-01851-xChristian U. Blank et al. Neoadjuvant nivolumab plus ipilimumab versus adjuvant nivolumab in macroscopic, resectable stage III melanoma: The phase 3 NADINA trial.. J Clin Oncol 42, LBA2-LBA2(2024). DOI:10.1200/JCO.2024.42.17_suppl.LBA2*Sponsor Disclaimer: Visit goremedical.com/btkpod to learn more about GORE® SYNECOR Biomaterial, including supporting references and disclaimers for the presented content.  Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. Rx only Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

We compare performance-driven CrossFit culture with health-first Outlast training through two athletes' real results, from autoimmune remission to rebuilt motivation and strength. We also share why we still do the CrossFit Open and how benchmarks and nutrition keep progress honest.• shifting from whiteboard scores to intrinsic motivation• endurance grit and identity formation as “Athlete Sherry”• Graves disease, cortisol management, and muscle gain• protein tracking, MyFitnessPal, and gamifying habits• no RX, coaching nudges, and choosing the right load• benchmarks for accountability without public ranking• community blend across Bison and Outlast during the Open• tempo training improving form, depth, and joint health• reassessing seasons of life, aging, and menopause impacts• what Outlast could add next for space and connectionThank you, everybody, for taking the time out of your day to listen to the Hurt Bit podcast. Be on the lookout for next week's episode.

Asher White is a songwriter and multi-instrumentalist based in NYC. Her newest release, Jessica Pratt, is a full album cover of Jessica Pratt's self-titled debut LP (out now on Joyful Noise). Asher share's her love for the Pratt record, the motivation behind covering an entire record and how the kernel of this idea may have stemmed from a tiny fib. She explains why the recording already written songs was both challenging and fun, how that changed her approach and how trust in someone else's writing played a role in the process. Asher tells us how she deals with noise and ambiance in her songwriting, why drums are the typically the last instrument on her recordings and Joe and Asher discuss the beauty of the “family computer”.Asher White Joyful NoiseThis episode supported by our friends at Izotope. This episode is produced with Ozone 12, the newest from Izotope. Head over to izotope.com now for savings on all their production software. Go check out Ozone 12 and RX 11 and master with the best and solve the unsolvable. Use code FRET10 at checkout.Ep supported by Distrokid . Distrokid now offers Bandzoogle where you can build your bands website and store in minutes. Tour stories listeners get 30% off at distrokid.com/vip/tourstories. GET YOUR MUSIC OUT THERE! ITS EASY WITH DistrokidEpisode sponsored by Schecter Guitars. Schecter Guitar Research is one of the world's premier guitar companies, offering electric guitars and basses, acoustic guitars, and USA Custom Shop instruments to musicians around the world.Its continually evolving and expanding line of guitars and basses appeals to a broad spectrum of players and diverse musical styles. They offer high-quality instruments with professional components at an affordable price. Go Schecter for all your guitar needsRuinous MediaKingston UnionMentioned in this episode:IzotopeSchecter GuitarsDistrokid

CC462: Lindsie and Kail discuss their differing co-sleeping philosophies, the challenges of managing kids' behavior and expectations. The conversation takes a serious turn as Kail shares her experience going from Adderall to Vyvanse, and the tragic death of a young man due to pharmaceutical price gouging. BOTH have some thoughts on the backlash against Bad Bunny's Super Bowl performance. Plus, a deep dive into the mysterious disappearance of Nancy Guthrie! Lastly, a hilarious Foul Play involving chicken alfredo and a deep throat gone wrong.Thank you to our sponsors!Better Help: This episode is brought to you by BetterHelp. Visit BetterHelp.com/coffee today to get 10% off your first month.K-12: Go to K12.com/COFFEECONVOS today to learn more!Quince: Go to Quince.com/coffee to get free shipping and 365-day returns on your next orderRoBody: Find out if you're covered for free at Ro.Co/COFFEECONVOS. Rx only.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

David Mazzei may well have the best-sounding turbocharged rotary on the planet, but how he chased down that elusive F1 V10 sound with this masterpiece of an engine is somewhat unexpected.Rotary engines are often labelled as temperamental and unreliable, but David Mazzei of Formula Mazzei believes the opposite. In his view, rotaries can be among the most reliable engines when properly understood.

What if helping the immune system find balance could meaningfully slow disease progression for diseases like ALS or Alzheimer's? In this episode of Rx for Biotech, host Chris Leidli sits down with Arun Swaminathan, CEO of Coya Therapeutics, to talk about a new and hopeful approach to treating neurodegenerative diseases by calming harmful inflammation in the body. This conversation offers a hopeful look at how science is working to improve quality of life for patients and families facing neurodegenerative disease. Arun also shares insights from his 20+ years in biotech leadership, including what it takes to advance novel immunology science in high-unmet-need indications and build a product pipeline across neurodegenerative, autoimmune, and inflammatory diseases.

In this episode of Finding Freedom, host John Odermatt examines the rise of GLP-1 drugs like Ozempic and Wegovy, exploring how they work by overriding the body's natural hunger signaling through synthetic peptides inspired by Gila monster venom. While acknowledging these medications have legitimate applications for severe obesity and diabetes, John raises concerns about FDA-listed side effects including muscle loss, stomach paralysis, and thyroid tumor warnings, especially as Trump's new RX.gov platform makes these drugs more affordable and accessible. Drawing from his personal experience losing 50 pounds and maintaining the weight loss, John argues that synthetic GLP-1s don't address root metabolic dysfunction caused by poor diet, sedentary lifestyle, and chronic inflammation. He advocates for natural alternatives like berberine, chromium polynicotinate, and polydextrose fiber that support the body's own GLP-1 production rather than overriding it. John emphasizes the importance of building sustainable habits through diet, exercise, and supplementation that restore metabolic function instead of creating pharmaceutical dependency. The episode concludes with a call to prioritize long-term health over quick fixes, warning that rapid weight loss without muscle maintenance could lead to premature aging and sarcopenia. CHAPTERS: 0:00 - Introduction: GLP-1 Drugs Overview0:54 - Welcome & Episode Preview1:16 - Sponsor: Fox and Sons Coffee2:18 - John's Personal Weight Loss Journey4:49 - Trump RX.gov Announcement & Concerns10:22 - What is GLP-1? Understanding the Science13:46 - FDA-Listed Side Effects & Risks17:12 - Root Causes of Metabolic Dysfunction20:22 - Natural Alternative #1: Berberine22:32 - Natural Alternative #2: Chromium Polynicotinate23:34 - Natural Alternative #3: Polydextrose Fiber27:15 - Lifestyle Balance & Sustainable Habits30:29 - The Danger of Quick Fixes31:47 - Natural Supplements Recap & Resources34:45 - Final Thoughts & Call to Action36:33 - Support Lions of Liberty LINKS: John Odermatt on Twitter: @JohnOdermattJohn Odermatt on Instagram: @JohnOdermattEmail: John@LionsofLiberty.comNewsletter: https://john-odermatt-finding-freedom.kit.com/105b53c794Trump RX.gov: https://trumprx.gov SPONSOR: This episode is brought to you by Fox and Sons Coffee – fresh, high-quality coffee shipped directly to your door, available as whole bean or ground to your preference. Get 15% off orders of $40 or more with promo code JOHN at checkout.Visit: FoxNSons.com SUPPORT LIONS OF LIBERTY: Help keep this podcast going! We rely on listener support to continue bringing you content on health, freedom, and personal empowerment.Support us on Patreon: https://patreon.com/lionsoflibertySupport us on Locals: https://lionsofliberty.locals.com/Subscribe, rate, and review wherever you listen – it makes a huge difference! Learn more about your ad choices. Visit megaphone.fm/adchoices

This episode walks you through this week's astrology + practical and magical tactics to help you harness and navigate the energetics February 9th - 15th, 2026. This week is definitely more. Venus goes for a swim, Mercury gets shady, and Saturn, officially shifts into Aries. Saturn's move is the one to watch. In general grounding is still our focus. Confusion ramps up, but so does the desire to create self-discipline around progress. Mo(o)nday, February 9th: We have significant shifts this week. Continue to focus on care of you so you can care for you and yours. We continue the long game that is 2025 - 2026. More of the energetics that are so major from 2025 take hold in 2026, this week and next. General reminder: The Year of the Snake (2025 energy) is still in play until next week Lunar New Year, February 17th - on the first eclipse of the season. This is when the Fire Horse energy officially begins. Until then, we are shedding, listening, evaluation, releasing, squirming to transform and let go. Don't look away, do not disassociate, escape, or look away. These are defining moments personally, and collectively. We are called to get radically honest about what bad behavior we have let slide and what we really, really, really want..from the depth of our soul....and to then take action towards said thing(s). We still have no personal planets in Earth. My loves, the issue of general stability is real. We will not have support from the astrology on this until March 30th (when Venus moves into Taurus) and May 2nd (When Mercury moves into Taurus). Grounding is everything this year. Mat, meditation, prayer, time alone, root veggies, nourishing food, decrease in caffeine, lifting heavy things, weighted blankets, hugs, slathered in vetiver and honey, conversations with safe community. All of your tools need to be at the ready and you'll need to stick to basics. This is one of those times when motivation will not serve. It's going to be self-discipline and adulting and understanding the long game. We have equal placements in Fire, Air, and Water and this is a nice harmony....again...in theory...without Earth it still feels chaotic, mutable, and in general unstable....because it is...and if we focus on harnessing all the mutability...we can create incredible outcomes because of it, not in spite. We are in transition. As an individual and as a collective. Focus on what you want. Participate at a pace and in ways you can. All is helpful, just please do not tap out completely. Boundaries, limits, expectations, and hopes continue to sharpen. This week as Saturn moves into Aries for the first time since 1999 we gain focus on self-discipline, ambition, responsibility, and self assertion. And although Saturn doesn't do so well in Pisces (where it's been since 2023), it's considered to be in its fall in Aries. I don't prescribe to binaries and try to stay away from it. In astrology nothing is good or bad...but there can be ease or challenges and this is definitely a challenge. It sets a fire under our collective asses. It has us all focusing on what is best for us as an individual (more equity) but we can see how that can create conflict and challenge if everyone individually is focused on personal centering, yes? To harmonize this, we must embrace intersectionality. Freedom for one, is freedom for none. Justice for one is justice for none. We rise together. We thrive together. Our practices are genuinely meant for this. When we calm and center ourselves, we can earnestly do the same for the collective and the future. Tiny and mighty. It still matters. It always matters. This transit takes us to task in a really good way. We will start stepping up in ways we have not before. Go with it. Embrace it. It's a 3 year process. On top of all of this, we're in the eclipse portal. We just need to be aware of how big all the energetics are right now. On top of no Earth in the chart, a shift from one of our major planets (Saturn) the Universe says it's time for buckets full of energy/magic to be dumped on us as it hits the reset button of astrology (power off/power on) in eclipse season. This eclipse portal begins now, essentially, and closes March 13th. This is the period of time we will be uttering "Plot twist! " "That was not on my bingo card for 2026" or "I did not see that coming." PLEASE REMEMBER these things can be incredible gifts, happy surprises, opportunities, and blessings! It is truly wild times with incredible potential and wonderful Easter eggs tucked in them. Stay curious about what your soul really wants, and stay focused and committed to what you want. Where attention goes, energy flows. Tuesday, February 10th: Day 1 of Supportive Solutions - You'll need a wall space for this workout. I know it can be a tricky prop to require, but again I'm a super fan of this no cost support that can also create resistance. Simple is best and always works. Venus in Pisces. This is a regular transition. Venus continues to move her way through the chart house by house. She stays in a sign an average of 4 weeks at a time. Venus loves to be here! We are here for this romantic, poetic, creative, backstroke through our fantasies and realities. Embrace this. Fuel this. Spend extra time with Aphrodite in this period of time (till March 6th) to expand, grow, and protect all the good things in our lives (friendships, networks, communities, partners....overall connections). They both want our desires to become a reality. This is one of the major Easter eggs of 2026. Wednesday, February 11th: Listen to The Magic Spark. Thursday, February 12th: Connect in The Unicorn Wellness Studio private member group. Friday, February 13th: It's Goddess Day! Time to ask: What does my inner goddess need in order to remember she is sacred, divine, and designed to receive? Today is actual Goddess Day - a Friday on the 13th. This is not bad luck, this is a historical celebration of the female divine, in its origin terms, in honor of the 13 moon cycles, our personal 13 moon cycles. It's truly an anti-patriarchal day. Reclaim it. Celebrate. Embrace creative life force, it's unlimited hope and potential to forever recreate, birth, make new, and begin again. However it calls to you, spend time at your altar, spend time with your vessel/body. Remind yourself of the potential YOU are and can generate and participate in. -Mercury Retroshade begins. We know the drill: ▪️Mercury stations retrograde 3xs a year ▪️The slow down prior to stationing Rx is called the pre-shadow or as I call it Retroshade. ▪️The actual Rx is lighter than the pre or post shadow. ▪️This week and next (Retroshade) is the brochure of the lesson/blessing we are to work with in this cycle. ▪️We will revisit this opportunity again in the Rx (February 26th - March 19th) and post shadow (March 20th - April 3rd). This Retrograde isn't great. I cannot sugar coat it. Mercury is not the best swimmer. Things get mucky, confused, poetic, and sound really great but could just be pretty words and empty promises. It could, at its best, offer feeling to heal things, honest words, the get raw and hit soul truths but will take effort after retrograde to bring to actual fruition. Triple check communications, travel, and finances. As clarifying questions. If you think you should check on something, DO. We will thrive and survive, but know this one isn't set up for ease. Check what house Pisces is in in your natal chart. This is where your themes and focus will be. This is great energy for making and creating. Focus on that. Craft, write, sing, dance, garden, cook....this is the way through. Saturn moves into Aries. Please see Monday. But here's the repeat: Saturn moves into Aries for the first time since 1999. We gain focus on self-discipline, ambition, responsibility, and self assertion. And although Saturn doesn't do so well in Pisces (where it's been since 2023), it's considered to be in its fall in Aries. I don't prescribe to binaries and try to stay away from it in the astrology...nothing is good or bad...but there can be ease or challenges and this is definitely a challenge. It sets a fire under our collective asses. It has us all focusing on what is best for us as an individual (more equity) but we can see how that can create conflict and challenge if everyone individually is focused on personal centering, yes? To harmonize this, we must embrace intersectionality. Freedom for one, is freedom for none. Justice for one is justice for none. We rise together. We thrive together. Our practices are genuinely meant for this. When we calm and center ourselves, we can earnestly do the same for the collective and the future. Tiny and mighty. It still matters. It always matters. This transit takes us to task in a really good way. We will start stepping up in ways we have not before. Go with it. Embrace it. It's a 3 year process. This is one of the major shifts we experienced a toe dip into in 2025 but takes root now, in 2026. Neptune and Saturn are travel partners these days. Delusion, dreams, and what it takes to bring outcomes to fruition is the lesson they are trying to teach the collective. Day 1 of Core Solutions - You'll need a set of yoga blocks for this workout. It's extra core focused and you'll be better supported with a cork set of blocks for stability and resistance. Saturday, February 14th: First day of New Moon Energy. We begin the down turn of energy today. But this is no regular new moon we're headed towards on the 17th. We're in the eclipse portal and the energy may have gotten weirder already, as early as Monday or Tuesday. This is a new moon so it's all about clearing the schedule for restoration, rejuvenation, rest, and meditation. Things will shift. Let them. Whatever is leaving, going, releasing....let it. Welcome in the new, emotional intelligence upgrade. Use your monthly meditation (it's a 3rd eye cleanse), work with any of the Energy Healings; Frequency or Goddesses in your UWS member library. Now is the time for recalibration and healings. Sunday, February 15th: Your weekly mantra. I surrender to the pivot. I embrace the plot twist. I keep my heart and mind focused on what I want, wish, and desire. I allow the upgrades, the reveals, the resets, and the fresh timelines. Our wildest dreams are still possible. We hold the vision. Additional Resources: Explore Mentoring Lite for the Spring/Summer session. We begin March 20th. Schedule an Exploration Call for Mentoring Lite February 28th - March 6th. UnicornWellnessStudio.com Offering 30-min Pilates based workouts in alignment to the astrological season and lunar cycles. Activate 30-day guest access at UnicornWellnessStudio.com Subscribe to Tandy's weekly newsletter Follow and DM on Instagram @tandy_gutierrez Additional episodes you might enjoy: EP 103: 2025 Year of the Snake: A Journey into the Heart of Lilith EP 140: Lilithian Language: Creating Boundaries and Bridges in a Single Breath.

In this episode of Finding Freedom, host John Odermatt examines the rise of GLP-1 drugs like Ozempic and Wegovy, exploring how they work by overriding the body's natural hunger signaling through synthetic peptides inspired by Gila monster venom. While acknowledging these medications have legitimate applications for severe obesity and diabetes, John raises concerns about FDA-listed side effects including muscle loss, stomach paralysis, and thyroid tumor warnings, especially as Trump's new RX.gov platform makes these drugs more affordable and accessible. Drawing from his personal experience losing 50 pounds and maintaining the weight loss, John argues that synthetic GLP-1s don't address root metabolic dysfunction caused by poor diet, sedentary lifestyle, and chronic inflammation. He advocates for natural alternatives like berberine, chromium polynicotinate, and polydextrose fiber that support the body's own GLP-1 production rather than overriding it. John emphasizes the importance of building sustainable habits through diet, exercise, and supplementation that restore metabolic function instead of creating pharmaceutical dependency. The episode concludes with a call to prioritize long-term health over quick fixes, warning that rapid weight loss without muscle maintenance could lead to premature aging and sarcopenia. CHAPTERS: 0:00 - Introduction: GLP-1 Drugs Overview0:54 - Welcome & Episode Preview1:16 - Sponsor: Fox and Sons Coffee2:18 - John's Personal Weight Loss Journey4:49 - Trump RX.gov Announcement & Concerns10:22 - What is GLP-1? Understanding the Science13:46 - FDA-Listed Side Effects & Risks17:12 - Root Causes of Metabolic Dysfunction20:22 - Natural Alternative #1: Berberine22:32 - Natural Alternative #2: Chromium Polynicotinate23:34 - Natural Alternative #3: Polydextrose Fiber27:15 - Lifestyle Balance & Sustainable Habits30:29 - The Danger of Quick Fixes31:47 - Natural Supplements Recap & Resources34:45 - Final Thoughts & Call to Action36:33 - Support Lions of Liberty LINKS: John Odermatt on Twitter: @JohnOdermattJohn Odermatt on Instagram: @JohnOdermattEmail: John@LionsofLiberty.comNewsletter: https://john-odermatt-finding-freedom.kit.com/105b53c794Trump RX.gov: https://trumprx.gov SPONSOR: This episode is brought to you by Fox and Sons Coffee – fresh, high-quality coffee shipped directly to your door, available as whole bean or ground to your preference. Get 15% off orders of $40 or more with promo code JOHN at checkout.Visit: FoxNSons.com SUPPORT LIONS OF LIBERTY: Help keep this podcast going! We rely on listener support to continue bringing you content on health, freedom, and personal empowerment.Support us on Patreon: https://patreon.com/lionsoflibertySupport us on Locals: https://lionsofliberty.locals.com/Subscribe, rate, and review wherever you listen – it makes a huge difference! Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of Finding Freedom, host John Odermatt examines the rise of GLP-1 drugs like Ozempic and Wegovy, exploring how they work by overriding the body's natural hunger signaling through synthetic peptides inspired by Gila monster venom. While acknowledging these medications have legitimate applications for severe obesity and diabetes, John raises concerns about FDA-listed side effects including muscle loss, stomach paralysis, and thyroid tumor warnings, especially as Trump's new RX.gov platform makes these drugs more affordable and accessible. Drawing from his personal experience losing 50 pounds and maintaining the weight loss, John argues that synthetic GLP-1s don't address root metabolic dysfunction caused by poor diet, sedentary lifestyle, and chronic inflammation. He advocates for natural alternatives like berberine, chromium polynicotinate, and polydextrose fiber that support the body's own GLP-1 production rather than overriding it. John emphasizes the importance of building sustainable habits through diet, exercise, and supplementation that restore metabolic function instead of creating pharmaceutical dependency. The episode concludes with a call to prioritize long-term health over quick fixes, warning that rapid weight loss without muscle maintenance could lead to premature aging and sarcopenia. CHAPTERS: 0:00 - Introduction: GLP-1 Drugs Overview0:54 - Welcome & Episode Preview1:16 - Sponsor: Fox and Sons Coffee2:18 - John's Personal Weight Loss Journey4:49 - Trump RX.gov Announcement & Concerns10:22 - What is GLP-1? Understanding the Science13:46 - FDA-Listed Side Effects & Risks17:12 - Root Causes of Metabolic Dysfunction20:22 - Natural Alternative #1: Berberine22:32 - Natural Alternative #2: Chromium Polynicotinate23:34 - Natural Alternative #3: Polydextrose Fiber27:15 - Lifestyle Balance & Sustainable Habits30:29 - The Danger of Quick Fixes31:47 - Natural Supplements Recap & Resources34:45 - Final Thoughts & Call to Action36:33 - Support Lions of Liberty LINKS: John Odermatt on Twitter: @JohnOdermattJohn Odermatt on Instagram: @JohnOdermattEmail: John@LionsofLiberty.comNewsletter: https://john-odermatt-finding-freedom.kit.com/105b53c794Trump RX.gov: https://trumprx.gov SPONSOR: This episode is brought to you by Fox and Sons Coffee – fresh, high-quality coffee shipped directly to your door, available as whole bean or ground to your preference. Get 15% off orders of $40 or more with promo code JOHN at checkout.Visit: FoxNSons.com SUPPORT LIONS OF LIBERTY: Help keep this podcast going! We rely on listener support to continue bringing you content on health, freedom, and personal empowerment.Support us on Patreon: https://patreon.com/lionsoflibertySupport us on Locals: https://lionsofliberty.locals.com/Subscribe, rate, and review wherever you listen – it makes a huge difference! Learn more about your ad choices. Visit megaphone.fm/adchoices

James Petralli is the singer, songwriter and founding member of the now Los Angeles based band, White Denim. The newest release 13 will hit the streets on April 24th via Bella Union. Second time guest Petralli share's the thoughtful and sonically aggressive nature behind the new record and how it relates to his personal experience his community and the state of affairs in the US. The two discuss James's approach to recording and his adherence to a collective process. They share thoughts on the band Geese, idiosyncratic songwriting, and creative integrity. Joe and James express their love for Italy, doodles and we get a taste of the newest, rip roaring, hard funk blues single, (God Created) Lock And Key.White DenimThis episode supported by our friends at Izotope. This episode is produced with Ozone 12, the newest from Izotope. Head over to izotope.com now for savings on all their production software. Go check out Ozone 12 and RX 11 and master with the best and solve the unsolvable. Use code FRET10 at checkout.Ep supported by Distrokid . Distrokid now offers Bandzoogle where you can build your bands website and store in minutes. Tour stories listeners get 30% off at distrokid.com/vip/tourstories. GET YOUR MUSIC OUT THERE! ITS EASY WITH DistrokidEpisode sponsored by Schecter Guitars. Schecter Guitar Research is one of the world's premier guitar companies, offering electric guitars and basses, acoustic guitars, and USA Custom Shop instruments to musicians around the world.Its continually evolving and expanding line of guitars and basses appeals to a broad spectrum of players and diverse musical styles. They offer high-quality instruments with professional components at an affordable price. Go Schecter for all your guitar needsRuinous MediaKingston UnionWhite DenimBella UnionMentioned in this episode:IzotopeSchecter GuitarsDistrokid

What happens when the world of GLP-1s collides with the operating room? Today, we're diving into the new era of obesity care. Hosts·       Matthew Martin, trauma and bariatric surgeon at the University of Southern California/Los Angeles General Medical Center (Los Angeles, California) @docmartin2·       Adrian Dan, bariatric and MIS surgeon, program director for the advanced MIS bariatric and foregut fellowship at Summa Health System (Akron, Ohio) @DrAdrianDan·       Crystal Johnson Mann, bariatric and foregut surgeon at the University of Florida (Gainesville, Florida) @crys_noelle_·       Katherine Cironi, general surgery resident at the University of Southern California/Los Angeles General Medical Center (Los Angeles, California) @cironimacaroniLearning objectives1.          Understand the evolving role of OMMs in bariatric surgical practice·       Recognize how widespread GLP-1 and dual-incretin therapies have reshaped patient presentations, expectations, and referral patterns.·       Appreciate current evidence comparing surgery to GLP-1 therapy, including the JAMA Surgery study out of Allegheny Health (2025), noting:o   Superior weight loss with bariatric surgery (~28% TBWL vs ~10% with GLP-1s)o   Higher health-care utilization and cost in GLP-1–treated patients.·       Frame OMMs not as alternatives but as complementary tools within a chronic disease model when treating obesity.2.           Review pharmacologic classes and their expected efficacy·       Surgeons should be able to articulate the mechanisms, efficacy, and limitations of:o   GLP-1 receptor agonists – incretin-based satiety; 5–12% TBWL.o   Dual GIP/GLP-1 agonists – most potent agents; 15–22% TBWL.o   Sympathomimetics – norepinephrine-driven appetite suppression; 3–7% TBWL.o   Combination agents (bupropion-naltrexone, phentermine-topiramate) – 5–12% TBWL depending on regimen.o   Emerging therapies – retatrutide, maritide, oral GLP-1s, with promising TBWL in phase 2 trials3.          Apply OMMs strategically in the preoperative phase·       Integrate OMMs without compromising surgical eligibility—OMM-related weight loss does not negate the indication for surgery.·       Counsel patients that medication response does not equal disease resolution; surgery remains the most durable intervention.·       Manage delayed gastric emptying and aspiration risk:o   Pause weekly GLP-1 or dual agonists for ≥1 week pre-op (longer if symptomatic).o   Collaborate closely with the anesthesia/OR teams·       Screen for nutritional depletion before surgery, especially protein deficits exacerbated by appetite suppression.·       Navigate insurance barriers that may paradoxically approve surgery but deny medication continuation.4.          Implement postoperative OMMs safely and effectively·       Establish criteria for OMM introduction:o   Typical initiation at 6–12 months, once the diet stabilizes and the physiologic curve flattens.o   Earlier initiation (4–6 weeks) may be appropriate in pediatric or select high-risk populations.·       Recognize altered pharmacokinetics after sleeve and bypass:o   Injectables may be preferred due to altered absorption of oral agents.·       Prevent postoperative nutritional compromise:o   Monitor protein intake, hydration, and micronutrient status (including iron, B12, and fat-soluble vitamins).o   Titrate doses slowly to minimize nausea/vomiting that can precipitate malnutrition.·       Frame OMM use as a tool for disease persistence (plateau/regain), not as a marker of failure.5.          Identify systems-level barriers and the implementation of coordinated care·       Understand insurance inconsistencies—coverage for surgery is often not paired with coverage for long-term medical therapy.·       Clearly document disease persistence and medical necessity when appealing denials.·       Avoid fragmented care: establish shared-care pathways between bariatric surgery, obesity medicine, and primary care.·       Use patient-centered language emphasizing complementary therapy, not hierarchy or competition between surgery and medications.6.          Counsel patients ethically and accurately within a chronic disease model·       Set expectations: sustained success requires surgery + medication + behavioral change.·       Educate patients that postoperative OMM use does not imply surgical failure.·       Normalize long-term multimodal management of obesity, analogous to diabetes or hypertension models.*Sponsor Disclaimer: Visit goremedical.com/btkpod to learn more about GORE® SYNECOR Biomaterial, including supporting references and disclaimers for the presented content.  Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. Rx only Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Salmon Sperm! Spicules! A Surgery-Free Face Lift! This week, it's a K-Beauty extravaganza as we sit down with board-certified dermatologist Dr. David Kim to unpack it all. Dr Kim is a Korean native with a newly-minted Manhattan practice, Soho Derm, that blends the best of cutting edge Korean aesthetics and western dermatology. Dr. Kim has over 1 million followers across social media and he's often featured as an expert on The Today Show. Tune in to hear about:Prevention vs. correction: Why patients in South Korea start treatments in their 20s compared to the “fix-it” mentality often seen in North AmericaThe “V-Line” vs. sculpted esthetic: Comparing the desire for heart-shaped, “feminine” facial features in Asia versus the "snatched" jaws in the West.PDRN (Salmon Sperm DNA): The science behind the viral ingredient, its 10-year history in Korea, and how it's being used for everything from joint recovery to glowy skin.The melasma solution: Why tranexamic acid (as an oral Rx) is a game-changer for pigment and the safety precautions you need to knowSpicules - friend or foe? What to know about the “Reedle” shots you see all over Tiktok and which one Dr. Kim is personally a fan ofThe treatments to know now: From Pico Laser to treat texture and dark spots to the Xerf tightening treatment that combats laxity, Dr. Kim shares his own personal experience as a guinea pig on what really makes a differenceWhat's on a derm's top shelf: Stay tuned to the end to hear about the one K-beauty skincare staple Dr. Kim believes everyone should own From derm-to-founder: What makes Dr. Kim's SPF brand, Lightsaver, different. Pssst - We have a special promo code: head to https://www.lightsaverskin.com and use code Breaking20 for a 20% discount!Get social with us and let us know what you think of the episode! Find us on Instagram, Tiktok,X, Threads. Join our private Facebook group. Or give us a call and leave us a voicemail at 1-844-227-0302. Sign up for our Substack here. Subscribe to our YouTube Channel to watch our episodes! For any products or links mentioned in this episode, check out our website: https://breakingbeautypodcast.com/episode-recaps/ Related episodes like this: Your Ultimate #DamnGood K-Beauty Shopping Guide is Here! Featuring Guest Host and Korean Skincare Expert Ava Lee AKA @GlowWithAva#DamnGood Special! Gothamista's Renée Chow Spills the Secrets of Her At-Home Skincare RoutineHow a K-Beauty Esthetician Gets Her Skin So Glassy with Peach & Lily Founder Alicia Yoon PROMO CODES: When you support our sponsors, you support the creation of Breaking Beauty Podcast! NutrafolNutrafol is the #1 dermatologist-recommended hair growth supplement brand, trusted by over 1.5 million people. See thicker, stronger, faster-growing hair with less shedding in just 3-6 months with Nutrafol. For a limited time, Nutrafol is offering our listeners $10 off your first month's subscription and free shipping when you go to Nutrafol.com and enter the promo code BREAKING.Skims Shop SKIMS Fits Everybody collection at SKIMS.com. After you place your order, be sure to let them know we sent you! Select “podcast” in the survey and be sure to select our show in the dropdown menu that follows. And if you are looking for the perfect gift for your Valentine or for yourself - the SKIMS Valentine's Shop is now open! #skimspartnerOne Skin OneSkin's OS-01 Peptide™ is proven to target the visible signs of aging, helping you unlock your healthiest skin now and as you age. For a limited time, get 15% off OneSkin with the code BREAKINGBEAUTY at https://www.oneskin.co/BREAKINGBEAUTY #oneskinpod. *Disclaimer: Unless otherwise stated, all products reviewed are gratis media samples submitted for editorial consideration.* Hosts: Carlene Higgins and Jill Dunn Theme song, used with permission: Cherry Bomb by Saya
 Produced by Dear Media Studio See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The Derm on RheumNow podcast is a collection of Citations and Content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, other CTD skin disorders. dermatology drugs, biiologics, JAKs - their use, efficacy and side effects.  Features Dr. Jack Cush, Editor at RheumNow.com.  SHOW NOTES Lupus Accelerating Breakthroughs Consortium commissioned a stakeholders group (including the FDA) to assess drug development in Cutaneous lupus CLE), and they have endorsed CLASI (CLE Dz Area & Severity Index) as the outcome measure for CLE clinical trials. https://t.co/q7If97AHBa PAPA Syndrome: When Sterile Inflammation Mimics Infection (Pyogenic Arthritis, Pyoderma gangrenosum, Acne) •A rare monogenic autoinflammatory disease •Caused by gain-of-function mutations in PSTPIP1

Andrew Becker is a multi-instrumentalist, composer, and founder Human Potential. The newest release Eel Sparkles in out on March 6th via What Delicate Recordings. Andrew tells us how band dynamic drove him start his solo project and why he puts music before self in his expression. He shares his approach to learning other instruments outside of drumming and why he dedicated himself to the craft of song writing. Joe and Andrew commiserate on the life changing power of the Bad Brains record Rock For Light, Charles Hayward's (This Heat) drumming iconic drumming style and we sample some tunes from Eel Sparkles. Human Potential Rock For LightThis HeatHetThis episode supported by our friends at Izotope. This episode is produced with Ozone 12, the newest from Izotope. Head over to izotope.com now for savings on all their production software. Go check out Ozone 12 and RX 11 and master with the best and solve the unsolvable. Use code FRET10 at checkout.Ep supported by Distrokid . Distrokid now offers Bandzoogle where you can build your bands website and store in minutes. Tour stories listeners get 30% off atdistrokid.com/vip/tourstories.GET YOUR MUSIC OUT THERE! ITS EASY WITH DistrokidEpisode sponsored by

This new mini-series on Behind the Knife will delve into the technical aspects of the Operative Standards for Cancer Surgery, developed through the American College of Surgeons Cancer Research Program. This second episode highlights the thyroid cancer operative standard.Hosts:Tracy Wang, MD, MPH, FACS is a Professor of Surgery and Vice-Chair of Strategic and Professional Development at the Medical College of Wisconsin with a clinical focus on endocrine surgical oncology. Vladmir Neychev, MD, PhD is a Professor of Surgery at the University of Central Florida College of Medicine with a clinical focus on endocrine surgical oncology.Jack Sample, MD (@JackWSample) is a General Surgery Resident at Mayo Clinic Rochester.Guests:Elizabeth Grubbs, MD (@EGrubbsMD) is a Professor of Surgical Oncology at MD Anderson where she specializes in endocrine tumors, with expertise in cancer of the thyroid.David Hughes, MD is a Clinical Associate Professor of Surgery at University of Michigan, where he focuses on surgical diseases of the endocrine system, including a particular focus on the diagnosis and management of papillary thyroid cancer.Learning Objectives: Understand key preoperative and intraoperative aspects of the evaluation and treatment of patients with biopsy-proven papillary thyroid carcinoma (PTC) greater than or equal to 1 cm. Define factors that guide decision making regarding the extent of surgical resection (lobectomy versus total thyroidectomy) for PTC.Links to Papers Referenced in this EpisodeOperative Standards for Cancer Surgery, Volume 2: Thyroid, Gastric, Rectum, Esophagus, Melanomahttps://www.facs.org/quality-programs/cancer-programs/cancer-surgery-standards-program/operative-standards-for-cancer-surgery/purchase/Kindle edition:Amazon.com: Operative Standards for Cancer Surgery: Volume 2, Section 1: Thyroid eBook : Program, American College of Surgeons Clinical Research, Katz, Matthew HG: Kindle StoreImpact of Extent of Surgery on Survival for Papillary Thyroid Cancer Patients Younger Than 45 years. https://pubmed.ncbi.nlm.nih.gov/25337927/ Extent of Surgery Affects Survival for Papillary Thyroid Cancer. https://pubmed.ncbi.nlm.nih.gov/17717441/Sponsor Disclaimer: Visit goremedical.com/btkpod to learn more about GORE® SYNECOR Biomaterial, including supporting references and disclaimers for the presented content.  Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. Rx only Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

This week Lindsie and Kail celebrate an eight-year anniversary and talk about the chaos of brand deals, from early regrets to their excitement over a new sponsorships. The conversation shifts to mental health, true crime documentaries, and discuss a dentist who allegedly committed insurance fraud by shooting off his own thumb before murdering his wife. Finally, they unpack the celebrity gossip.Thank you to our sponsors!Better Help: This episode is brought to you by BetterHelp. Visit BetterHelp.com/coffee today to get 10% off your first month.Cozy Earth: Go to cozyearth.com/COFFEECONVOS for up to 20% off!Progressive: Visit Progressive.com to learn more!SKIMS: Check out our favorite bras and underwear at http://www.skims.com/coffeeRoBody: Find out if you're covered for free at Ro.Co/COFFEECONVOS. Rx only.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of NP Pulse: The Voice of the Nurse Practitioner®️, Drs. Eric Lenze and Megan Morgenthaler will discuss evidence-based treatments for older adults living with treatment-resistant depression using the findings from the Antidepressant Augmentation versus Switch in Treatment-Resistant Geriatric Depression study. Treatment-resistant depression is a form of major depressive disorder that has not responded to at least two antidepressant treatments. Upon successful completion of this podcast, you will be able to: Define treatment-resistant depression in older adults. Describe how to use medication augmentation/switching for treatment-resistant depression. Explain one approach to deprescribing medications for older adults. This episode was developed as part of the American Association of Nurse Practitioners'® (AANP) Clinical Effectiveness Research Initiative, which is funded by a Eugene Washington Patient-Centered Outcomes Research Institute Engagement Award (EADI #35224).  A participation code will be provided at the END of the podcast — make sure to write this code down. Once you have listened to the podcast and have the participation code, return to this activity in the AANP CE Center and follow these steps: Register for this activity. Click on the "Next Steps" button. Enter the participation code that was provided. Complete the activity evaluation. This will award your continuing education (CE) credit and certificate of completion. 0.75 CE, 10 RX, will be available through Dec. 31, 2027. Please see below for links to resources that the speakers mentioned in the episode. Substance Abuse and Mental Health Services Administration (SAMHSA): Treatment Services Locator for finding local mental health providers and 988 Suicide & Crisis Lifeline with 24/7 support. National Alliance on Mental Illness (NAMI): Education material on depression and treatment as well as local and virtual support groups for patients and families. Depression and Bipolar Support Alliance (DBSA): In-person and virtual peer-led support groups fostering connection and encouragement. DBSA also has information on wellness tools and community resources. National Coalition on Mental Health and Aging (NCMHA): Provide access to depression screening tools and caregiver guides. National Council on Aging (NCOA): Offers senior-friendly mental health education and coping strategies.

The Left has officially lost the plot. Now they’re coming after whole milk—claiming it’s not just white… it’s racist. Yes, really. Today on Stinchfield, we expose the latest example of woke ideology eating itself, where even your grocery cart isn’t safe from political insanity. When common sense becomes controversial and food is turned into propaganda, you know the culture war has jumped the shark. Also, GLP-1 weight-loss drugs were sold as a miracle. Now older Americans are quietly walking away from them—and the media doesn’t want to talk about why. We dig into the real data, the side effects, the long-term risks, and why seniors are saying “no thanks” to the pharmaceutical hype. If you’ve been told this is the magic solution to your weight lose challenges, you need to hear what they aren't telling you. If you’re ready to take back control of your health, check out The Wellness Company. Get Ready to take 10% off all your favorite products from Rx to Supplements, Prescription Medication Emergency Kits, Parasite Detox and more at https://TWC.Health/Grant. Use Promo code "Grant" See omnystudio.com/listener for privacy information.

Host: Darryl S. Chutka, M.D.  Guest: Stephen Kopecky, M.D.  One of the biggest surprises we've seen in medicine in the past several years has been the numerous health benefits realized from the GLP-1 agonists. Originally developed for the management of diabetes, they've shown significant potential to improve cardiovascular risks, beyond controlling blood glucose and lowering hemoglobin A1c. Several studies have shown reductions in cardiovascular events including MI, stroke as well as reducing overall cardiovascular death. What is the mechanism of action for these cardiovascular benefits? Are there any differences in the various GLP-1 medications available and who's a candidate for a GLP-1 medication? I'll get answers to all of these questions and more in this podcast as I speak with Dr. Stephen Kopecky, a preventive cardiologist at the Mayo Clinic. We'll be discussing “GLP-1 Agonists and Reducing Cardiovascular Risk”.  Rx for Weight Loss: A Closer Look Series | Mayo Clinic School of Continuous Professional Development  Learn more at https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

Strength vs Lungs. Linchpin data. Set loads vs % Workouts I regret. CF Open. Banded Bar Muscle-ups btwb fitness level Lateral movements My personal preferences for workouts. Strength + Metcon = mediocre results De-load weeks Using Linchpin to prepare for BUD/s Rate of Perceived Exertion Overcoming Low Motivation Progressing from Scaled to RX gymnastics Mobility work. Modifications for pregnancy

Louis Bradshaw is the drummer and a founding member of Brighton based band Plantoid. They're second full-length album Flare is set to be released on January 30 via Bella Union records. Louis tells us how the new record quickly slipped from a writing session to a recording session on the edge of the Welsh national park, Snowdoina. We learn why the band pivoted from a live recording approach to a more intentional slowed down and thoughtful process.The two discuss the role of repetition on the new songs and how that created a platform for a more emotive expression. The two drummers successfully avoid talking about drums the entire episode and we hear a few new tune.PlantoidBella UnionThis episode supported by our friends at Izotope. This episode is produced with Ozone 12, the newest from Izotope. Head over to izotope.com now for savings on all their production software. Go check out Ozone 12 and RX 11 and master with the best and solve the unsolvable. Use code FRET10 at checkout.Ep supported by Distrokid . Distrokid now offers Bandzoogle where you can build your bands website and store in minutes. Tour stories listeners get 30% off atdistrokid.com/vip/tourstories.GET YOUR MUSIC OUT THERE! ITS EASY WITH DistrokidEpisode sponsored by Schecter Guitars. Schecter Guitar Research is one of the world's premier guitar companies, offering electric guitars and basses, acoustic guitars, and USA Custom Shop instruments to musicians around the world.Its continually evolving and expanding line of guitars and basses appeals to a broad spectrum of players and diverse musical styles. They offer high-quality instruments with professional components at an affordable price. Go Schecter for all your guitar needs

In this episode, Kail and Lindsie dive deep into the changing definitions of success, prioritizing peace and stability over chaos. They share on whether a cheater can truly be reformed, the exhausting nature of maintaining fake friendships to avoid conflict, and the emotional struggle of being a twin mom. Plus, they explore the difficulty of maintaining privacy while living in the public eye and navigating an identity crisis after leaving reality TV.Thank you to our sponsors!Chime: Get started at chime.com/coffeeFabletics: Head to Fabletics.com/coffeeconvos and sign up as a VIP to get 80% off everything.Progressive: Visit Progressive.com to learn more!Rocket Money: Cancel unwanted subscriptions by going to RocketMoney.com/COFFEECONVOSRoBody: Find out if you're covered for free at Ro.Co/COFFEECONVOS. Rx only.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Picture this: a patient with early-stage breast cancer is sitting in front of you in the clinic. You are about to offer your expert management plan. The age-old question arises—should you really perform a sentinel lymph node biopsy, or could omission actually help this patient more? Today, we're tackling one of the hottest debates in modern breast cancer care.Should we rethink sentinel lymph node biopsy for select patients, and can skipping it actually improve quality of life without sacrificing cancer control? The stakes couldn't be higher—balancing accurate cancer staging and minimizing harm is the name of the game. Together, we're breaking down the latest evidence from the SOUND and INSEMA trials. What do these landmark studies mean for your patients, your practice, and the future of axillary management? Ready for a journal review that might just change your next consult? Hosts:- Rashmi Kumar, MD, PhDResident, University of Michigan General Surgery Residency ProgramTwitter/X: @RashmiJKumar- Melissa Pilewskie, MDAttending Breast Surgical Oncologist, Co-Director of the Weiser Family Center for Breast Cancer, Michigan Medicine Twitter/X: @MPilewskie- Stephanie Downs-Canner, MDAttending Breast Surgical Oncologist & Physician-Scientist, Memorial Sloan Kettering Cancer Center, Program Director of the Breast Surgical Oncology Fellowship Training Program Twitter/X: @SDownsCannerLearning Objectives:- Understand when and for whom it is safe and beneficial to omit sentinel lymph node biopsy (SLNB) in early-stage breast cancer patients.- Identify the risks associated with foregoing SLNB, including loss of nodal staging, and analyze how this impacts treatment selection and prognosis.- Review key findings from the SOUND and INSEMA trials and their influence on axillary management.- Discuss implications for adjuvant therapy, genomic profiling, and multidisciplinary clinical practice.- Recognize which patient populations should still receive SLNB, and the importance of individualized, multidisciplinary decision-making.References:- Gentilini OD, Botteri E, Sangalli C, et al. Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial. JAMA Oncol. 2023;9(11):1557–1564. doi:10.1001/jamaoncol.2023.3759 https://pubmed.ncbi.nlm.nih.gov/37733364/- Reimer T, Stachs A, Veselinovic K, et al. Axillary surgery in breast cancer – primary results of the INSEMA trial. N Eng J Med. 2024. doi:10.1056/NEJMoa2412063.https://pubmed.ncbi.nlm.nih.gov/39665649/- Sparano JA, Gray RJ, Makower DF, Albain KS, Saphner TJ, Badve SS, Wagner LI, Kaklamani VG, Keane MM, Gomez HL, Reddy PS, Goggins TF, Mayer IA, Toppmeyer DL, Brufsky AM, Goetz MP, Berenberg JL, Mahalcioiu C, Desbiens C, Hayes DF, Dees EC, Geyer CE Jr, Olson JA Jr, Wood WC, Lively T, Paik S, Ellis MJ, Abrams J, Sledge GW Jr. Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial. JAMA Oncol. 2020 Mar 1;6(3):367-374. doi: 10.1001/jamaoncol.2019.4794. PMID: 31566680; PMCID: PMC6777230. https://pubmed.ncbi.nlm.nih.gov/31566680/- Slamon DJ, Fasching PA, Hurvitz S, Chia S, Crown J, Martín M, Barrios CH, Bardia A, Im SA, Yardley DA, Untch M, Huang CS, Stroyakovskiy D, Xu B, Moroose RL, Loi S, Visco F, Bee-Munteanu V, Afenjar K, Fresco R, Taran T, Chakravartty A, Zarate JP, Lteif A, Hortobagyi GN. Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2- early breast cancer. Ther Adv Med Oncol. 2023 May 29;15:17588359231178125. doi: 10.1177/17588359231178125. Erratum in: Ther Adv Med Oncol. 2023 Sep 29;15:17588359231201818. doi: 10.1177/17588359231201818. PMID: 37275963; PMCID: PMC10233570. https://pubmed.ncbi.nlm.nih.gov/37275963/Sponsor Disclosure: Visit goremedical.com/btkpod to learn more about GORE® SYNECOR Biomaterial, including supporting references and disclaimers for the presented content. Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. Rx only Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Host: Darryl S. Chutka, M.D.  Guests: Tamim I. Rajjo, M.D., M.P.H.; Meera Shah, M.B., Ch.B.  The class of medications known as the GLP-1 agonists is very popular with our patients. Although initially indicated for management of diabetes, they're frequently taken for the weight loss they commonly produce. How long should these medications be taken? Is there anything we can do to help maintain the weight loss achieved with these medications? How significant is the loss of muscle mass which can occur as part of the weight lost with these medications and can this be minimized. Finally, how safe are the compounded and unapproved versions of these medications patients often find more affordable? These are a few of the questions we'll address in podcast on the GLP-1 medications used for weight loss and we'll tackle the “Controversies and Future of the GLP-1 Medications”. My guests include Dr. Meera Shah and Dr. Tamim Rajjo, both from the Division of Endocrinology at the Mayo Clinic.  Rx for Weight Loss: A Closer Look Series | Mayo Clinic School of Continuous Professional Development  Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

Today on Stinchfield, we break down a stunning reversal from the CDC. After decades of insisting the childhood vaccine schedule was untouchable, the agency has quietly slashed it—from 88 total doses down to roughly 30. That is not a tweak. That is an admission. For years, parents raised concerns about stacking vaccine after vaccine on developing immune systems, only to be dismissed, mocked, or accused of being anti science. Now the CDC is effectively acknowledging what common sense and many courageous doctors have been saying all along: more is not always better, especially when it comes to children. We explain why this change could dramatically reduce adverse vaccine side effects, why individualized, risk based medicine matters, and how parental choice is finally being restored after years of government arrogance. The question now is simple—if this protects children, why did it take so long? If you’re ready to take back control of your health, check out The Wellness Company. Get Ready to take 10% off all your favorite products from Rx to Supplements, Prescription Medication Emergency Kits, Parasite Detox and more at https://TWC.Health/Grant. Use Promo code "Grant"See omnystudio.com/listener for privacy information.

Ever feel powerless in the clinical environment? You're not alone - and you may have more power than you think. In this Clinical Challenges in Surgical Education, hosts Drs. Maya Hunt and Mckenzie Rowe explore power and leadership within surgical learning environments. Joined by guests Drs. Paula Ferrada, Chair of Surgery at Inova Fairfax, and Frances Mei Hardin, co-founder of the Hippocratic Collective, the team discusses frameworks of conceptualizing power, how it can be found at any point in training, and tips on how to identify and better wield our own power in learning environments. Episode Hosts: Dr. Maya Hunt, Indiana University, mayahunt@iu.edu    Dr. Mckenzie Rowe, Inova Fairfax, mckenzie.rowe@inova.org   CoSEF: @surgedfellows, cosef.org    Guests:  Dr. Paula Ferrada, Inova Fairfax, @pferrada1, paula.ferrada@inova.org Dr. Frances Mei Hardin, Hippocratic Collective, @francesmeimd, francesmei@hippocratic-collective.com Learning Objectives: Identify different sources of power within individuals Define framework of ‘power-over' vs. ‘power-to/power-with' Recognize how leaders (including residents) may wield different types of power in both harmful and helpful ways Spark self-reflection upon how each of us wields our own power in our role References: Brown B. Brené Brown on Power and Leadership. https://brenebrown.com/resources/brene-brown-on-power-and-leadership/.  Pansardi P, Bindi M. The new concepts of power? Power-over, power-to and power-with. Journal of Political Power. 2021;14(1):51-71. doi:10.1080/2158379x.2021.1877001  Bolman LG, Deal TE. Power, Conflict, and Coalition. In: Reframing Organizations: Artistry, Choice, and Leadership. 7th ed. Jossey-Bass; 2021:187-207.  Ferrada P. Breaking the silence: Addressing toxic leadership to restore psychological safety in healthcare. Forbes. October 8, 2025. https://www.forbes.com/councils/forbesbusinesscouncil/2025/10/08/breaking-the-silence-addressing-toxic-leadership-to-restore-psychological-safety-in-healthcare/.  Sponsor Disclaimer: Visit goremedical.com/btkpod to learn more about GORE® SYNECOR Biomaterial, including supporting references and disclaimers for the presented content. Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. Rx only Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listen Behind the Knife Premium: General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Dominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotation Vascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-review Colorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-review Surgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-review Cardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-review Download our App: Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

CC453: Kail and Lindsie dive into the chaos of family life, including a fear of Hand, Foot, and Mouth Disease spreading at school. Plus, they share their unpopular opinion on the Diddy docuseries, debate if Cheesecake Factory is fast-casual, and discuss their recent attempts at home cooking. Lastly, they offer advice to a new mom dealing with a mother-in-law who insists on waking up their baby and calls her "spoiled"Thank you to our sponsors!Chime: Get started at chime.com/coffeeQuince: Go to Quince.com/coffee to get free shipping and 365-day returns on your next orderRoBody: Find out if you're covered for free at Ro.Co/COFFEECONVOS. Rx only.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.